WO2005063705A1 - 1,2-ジ(環式基)置換ベンゼン化合物 - Google Patents
1,2-ジ(環式基)置換ベンゼン化合物 Download PDFInfo
- Publication number
- WO2005063705A1 WO2005063705A1 PCT/JP2004/019795 JP2004019795W WO2005063705A1 WO 2005063705 A1 WO2005063705 A1 WO 2005063705A1 JP 2004019795 W JP2004019795 W JP 2004019795W WO 2005063705 A1 WO2005063705 A1 WO 2005063705A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound
- alkyl
- substituent selected
- membered
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Definitions
- the present invention relates to 1,2-di (cyclic group) -substituted benzene compounds, salts thereof, or hydrates thereof, which are useful as cell adhesion inhibitors or cell invasion inhibitors.
- the present invention also relates to 1,2-di (cyclic group) -substituted benzene compounds, salts thereof or hydrates thereof, which are useful as agents for treating or preventing inflammatory diseases and autoimmune diseases.
- the present invention relates to leukocyte adhesion and infiltration of inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, atopic dermatitis, etc.
- the present invention relates to a 1,2-di (cyclic group) -substituted benzene compound, a salt thereof, or a hydrate thereof, which is useful as a therapeutic or preventive agent for various diseases caused by the above.
- Leukocyte infiltration is defined as the activation of leukocytes such as neutrophils and lymphocytes by cytokins, chemokines, lipids, complement, etc., resulting in cytokines such as IL-1 and TNFa. It interacts with vascular skin cells activated by 4, called rolling or tethering, adheres to vascular endothelial cells, and then migrates to extravascular and peripheral tissues. .
- a therapeutic or preventive agent for inflammatory bowel disease (ulcerative colitis, Crohn's disease, etc.) (see Non-Patent Documents 1, 2, and 3)
- Non-Patent Document 8 A therapeutic or prophylactic agent for asthma (see Non-Patent Document 8)
- Non-Patent Document 9 A therapeutic or prophylactic agent for atopic dermatitis (see Non-Patent Document 9)
- substances that inhibit cell adhesion or cell infiltration are useful as agents for treating or preventing inflammatory diseases and autoimmune diseases, including inflammatory bowel diseases (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, and rheumatoid arthritis. It is expected to be useful as a therapeutic or prophylactic agent for various diseases caused by leukocyte adhesion and infiltration, such as psoriasis, multiple sclerosis, asthma, and atopic dermatitis.
- a compound having an anti-inflammatory effect based on suppression of adhesion between leukocytes and vascular endothelial cells or a compound having an anti-inflammatory effect based on suppression of leukocyte infiltration hereinafter, referred to as a cell adhesion inhibitor and a cell infiltration inhibitor, respectively.
- the compound represented by the general formula (1) according to the present invention has a benzene ring (having a piperazine or piperidine at an ortho position) to which an aliphatic carbocyclic group such as a cyclohexyl group is bonded. Since they are characterized by containing a partial chemical structure, their compound structures are different from these cell adhesion inhibitors or cell invasion inhibitors.
- the compound represented by the general formula (1) according to the present invention which is a chemical structural characteristic, is a piperazine or a piperazine at an onoleto position of a benzene ring to which an aliphatic carbocyclic group such as a cyclohexyl group is bonded.
- Compounds having a partial chemical structure having a lysine include, for example,
- Patent Document 2 Is known (see Patent Document 2).
- the application only describes the use of the compound as an anti-obesity agent based on the melanocortin receptor agonist action and as a therapeutic agent for diabetes. There is no description or suggestion about the intended use.
- Patent Document 1 International Publication No. 2002/0 1 8 3 20 Pamphlet
- Patent Document 2 International Publication No. 2002/0 5 9 1 08 Pamphlet
- Non-Patent Document 5 Rheumatoid arthritis (Int. J. Biochem. Cell Biol., 36:
- Non-Patent Document 6 Psoriasis (Lancet, 361: 1197-1204 (2003))
- Non-Patent Document 7 New and emerging treatment options for multiple sclerosis (Lancet Neurology, 2: 563-566 (2003))
- Non-Patent Document 8 The role of T lymphocytes in the pathogenesis of asthma
- Non-Patent Document 9 The molecular basis of lymphocyte recruitment to the skin (J. Invest. Dermatol., 121: 951-962 (2003))
- Non-Patent Document 10 Discovery of 2-(4-pyridin-2-ylpiperazin-1-yl methyl)-1H- benzimidazo ⁇ e (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction (J. Med.Chem., 47: 3853-3864 (2004))
- An object of the present invention is to prevent the adhesion and infiltration of leukocytes such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, and atopic dermatitis.
- An object of the present invention is to provide a novel compound having an excellent cell adhesion-suppressing action and a function for producing cell infiltration, which is useful as a therapeutic or preventive agent for various inflammatory diseases and autoimmune diseases caused by such diseases.
- a 1,2-di (cyclic group) -substituted benzene compound having a novel chemical structure which is the above problem, has an excellent cell adhesion inhibitory action or cell infiltration. It has an inhibitory effect, especially on leukocytes such as inflammatory bowel disease (especially ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, and atopic dermatitis.
- leukocytes such as inflammatory bowel disease (especially ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, and atopic dermatitis.
- the present inventors have found that they are useful as agents for treating or preventing various inflammatory diseases and autoimmune diseases caused by adhesion and infiltration, and completed the present invention.
- the present invention is a compound having the following general formula (1) or (100), a salt thereof, or a hydrate thereof.
- the present invention is a medicament containing a compound having the above general formula (1) or (100), a salt thereof, or a hydrate thereof.
- the present invention is a cell adhesion inhibitor or a cell infiltration inhibitor lj containing a compound having the above general formula (1) or (100) or a salt or hydrate thereof.
- the present invention is a therapeutic or prophylactic agent for inflammatory diseases and autoimmune diseases, comprising a compound having the above general formula (1) or (100) or a salt or hydrate thereof.
- the present invention relates to an inflammatory bowel disease (particularly ulcerative colitis or pulmonary Crohn's disease) containing a compound having the general formula (1) or (100) or a salt or hydrate thereof. It is a therapeutic or prophylactic agent for irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma or atopic dermatitis.
- the present invention relates to the use of a compound having the above general formula (1) or (100), a salt thereof, or a hydrate thereof for producing a medicament.
- R 10 may have a 5- to 1-membered cycloalkyl group which may have a substituent selected from the following group A1 or a substituent selected from the following A1 group. Represents a 10-membered cycloalkenyl group,
- R 20, R 21, 122 and 23 are the same or different and are a hydrogen atom, water Acid group, halogen atom, cyano group, C2-7 alkylcarbonyl group, nitro group, amino group, mono (C1-6 alkyl) amino group, di (.C1-6 alkyl) amino group, B1 below
- a C16 alkyl group optionally having a substituent selected from the group; a C16 alkoxy group optionally having a substituent selected from the following B1 group; the following C1 group 4 to 8 membered heterocyclic group which may have a substituent selected from
- C represents a 5- to 10-membered heteroaryl group which may have a substituent selected from Group 1.
- R 30, R 31, and R 32 are the same or different and each represents a hydrogen atom, a hydroxyl group, a halogen atom, a cyano group, a carboxyl group, a C 1-6 alkyl group, a C 1-6 anoroxy group or a C 2 — Represents a 7 alkoxycarbonyl group, or
- R 30, R 31 or R 32 are taken together to form an oxo group (formula —O group) or a methylene group (formula CH 2— group), and the other one is a hydrogen atom , A hydroxyl group, a halogen atom, a cyano group, a carboxyl group, a C1.6 alkyl group, a C1.6 alkoxy group or a C1.7 alkoxy radical,
- R 40 may have a substituent selected from the following D 1 group, and may have a substituent selected from the following E 1 group.
- An 8-membered cycloalkyl group which may have a substituent selected from the following group E 1- to 8-membered tetracyclic group, which may have a ⁇ substituent selected from the following group F 1 C 2-7 alkenyl group, optionally having a substituent selected from the following group F 1 C 2 _ 7 alkynyl group, optionally having a substituent selected from the following group G 1 2-7 alkynolecarbonyl group, mono (C1-6 alkyl) aminocarbonyl group, 418-membered heterocyclic group Rupolyl group, C2-7 anorecoxycarbonyl group or C1-6 phenol A quinolesnorehono group,
- ⁇ represents an integer of 0, 1 or 2
- XI represents a formula group or a nitrogen atom
- Group A 1 includes a hydroxyl group, a halogen atom, a cyano group, a C16 alkoxy group, A phenyl group which may have a substituent selected from a group, a C 1-6 alkyl group, a C 1-6 haloalkyl group, a C 2-7 alkylene; an X group (provided that the A 10-membered cycloalkyl group or a substituted 5- to 10-membered cycloalkenyl group only when a spiro bond is formed),
- Group B 1 represents a group consisting of a halogen atom, a C 2-7 alkoxycarbonyl group and a carboxy group,
- Group C1 represents a group consisting of a cyano group, a halogen atom, a C1_6 alkyl group and a C1-6 alkoxy group,
- Group D 1 includes a hydroxyl group, a halogen atom, a cyano group, a C1-6 alkoxy group, a C1-6 alkylthio group, a C1-6 alkylsulfonyl group, a C1-6 alkylsulfinyl group, a mono (C1 6-alkyl) amino group, di (C1-6alkyl) amino group, C2-7-alkylcarbonylamino group, 3- to 8-membered cycloalkyl optionally having a substituent selected from the following group H1 Group, C 2-7 alkoxyl alkoxyl group, carboxyl group, 4- to 8-membered heteroaryl group, 5- to 10-membered heteroaryl group, 6-10-membered aryl group, C2-7 alkylcarbonyl Group, 6- to 10-membered aryl ring carbonyl group, aminocarbonyl group, mono- (C 16 alkyl) amino group optionally substituted with halogen atom, mono- (3
- Group F 1 represents a group consisting of a P gene atom and a C 16 alkoxy group
- Group G 1 represents a group consisting of a 3-8 membered cycloalkyl group
- Group H1 includes a hydroxyl group, a C1-6 haloalkyl group, a C1-6 alkyl group, a C2-7 alkoxyalkyl group, a mono (C1-6 alkyl) aminocarbinole group, and a di (C1-6 alkyl) group. It represents a group consisting of an aminocarbonyl group, a C 2-7 alkoxycarbo-nore group, a carboxyl group and a C 2-7 cyanoalkyl group.
- Examples of the “5-10-membered cycloalkyl group” of the “5-1-10-membered cycloalkyl group optionally having a substituent selected from the following A1 group” of R 10 include, for example, , Cyclohexynole, cycloheptyl, cyclooctyl, cyclononole or cyclodecyl group, preferably cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl group, particularly preferably cyclohexyl / cyclohexyl group. Group.
- cyclopentyl (1-cyclopentenyl, 2-cyclopenteninole, 3-cyclopenteninole), cyclohexene / le (1-cyclohexenelinole, 2-cyclohexeninole , 3-cyclohexeninole), cyclohepteninole (1-sic mouth heptul, 2-sic mouth heptenyl ', 3-sic mouth heptenyl), 4-cycloheptenyl, 4-cycloheptenyl, 2-cycloheptenyl Cycloota Thule, 3-cyclooctenole, 4-six mouth otatul '), cyclononenone (1-cyclononeninore, 2-cyclononenone
- halogen atom examples include a fluorine, chlorine, bromine or iodine atom, and preferably a bromine, fluorine or chlorine atom It is.
- C 2-7 alkyl carbonyl group refers to a “C 16 alkyl group” described later.
- “Group” is a carbonyl group bonded to, for example, acetyl, ethylcarbo-norre, n-propynolecarbonole, isopropylcarbonyl, n-ptinolecanoleponinole, isobutynolecanolebonyl, s-ptinolecanone Levonyl, t-butyl canoleboninole, pentynolecanoleboninole, isopentyl canoleboninole, 2-methinolebutinolecanolenone, neopentylcarbonyl, 1-ethylpropinolecanolebonyl, hexinolecarbonyl Nore, isohex
- 2-Methynolepentinolecanoleponinole 1-methylpentylcanoleboninole, 3,3-Dimethylbutylcarbinole, 2,2-Dimethinoleptylcarbonyl, 1,1-Dimethinolev'tylcarbonyl, 1 Linear or 2,3-dimethylbutylcarbonyl, 1,3-dimethylbutylcarbonyl, 2,3-dimethylbutynolecanolebonyl, 1-ethylbutylcanoleboninole or 2-ethylbutylcarbonyl group
- Examples include branched-chain ones, preferably C 2-5, and particularly preferably acetyl or ethylcarbo. Nyl group.
- Examples of the “mono, (C 1-6 alkyl) amino group” of R 20, R 21, R 22 and R 23 include, for example, meth / reamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, isopentylamino, 2-methylbutylamino, neopentylamino, 1-ethylpropylamino, hexylamino, isohexylamino, 4-methylpentylamino , 3-methylpentylamino, 2-methylpentylamino, 1-methinolepentinoleamino, 3,3-dimethylbutinoleamino, 2,2-dimethylinobutylamino, 1,1-dimethylbutylamino, 1 1,2-dimethylbutylamino, 1,3-dimethyl
- the “di (C 1-6 alkyl) amino group” of R 20, R 21, R 22 and R 23 may be symmetric or asymmetric, for example, dimethylamino, methylethylamino, getylamino. , Methylpropylamino, ethylpropylamino, dipropylamino, diisopropylamino, dibutylamino, disoptylamino, di (s-butynole) amino, di (t-butylinole) amino, methylpentinoleamino, dipentylamine, disopentamine / Reamino, di (2-methylbutyl) amino, di (neopentinole) amino, di (1-ethynolepropyl) amino, dihexyl / reamino, methylisohexylamino, diisohexylamino, di (4-methylpentyl) amino, di (3-methylpentyl) amino, di
- C 1-6 alkyl group of the “C 1-6 alkyl group optionally having a substituent selected from the following B 1 group” of R 20, R 21, R 22 and R 23
- B 1 group of R 20, R 21, R 22 and R 23
- the “C 1-6 alkoxy group” of the “C 16 alkoxy group which may have a substituent selected from the following B 1 group” of R 20, R 21, R 22 and R 23 "Includes, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentoxy, isopentoxy, 2-methynolebutoxy, neopentoxy, hexinoleoxy, 4-methinolepentoxy, 3-Methynolepentoxy, 2-methylpentoxy, 3,3-dimethylbutoxy, 2,2-dimethylbutoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy or 2,3 — Straight-chain or branched ones such as a dimethylbutoxy group, preferably methoxy, ethoxy, propoxy or isopropoxy.
- heterocyclic group means a monovalent group obtained by removing one hydrogen atom at an arbitrary position from the following “418-membered heterocyclic ring”.
- the “4- to 8-membered heterocyclic ring” is a non-aromatic ring having 4 to 8 ring-forming atoms and having one or more heteroatoms in the ring-forming atoms.
- (Fully saturated ring or partially unsaturated ring) for example, azetidine ring, pyrrolidine ring, piperidine ring, azepane ring, azocan ring, tetrahydrofuran ring, tetrahydropyran ring, tetrahydrothiopyran ring, morpholine ring , Thiomorpholine ring, piperazine ring, diazepan ring, thiazolidine ring, isoxazolidine ring, imidazolidin ring, villazolidine ring, dioxane ring, 1,3-dioxolane ring, oxaxian ring, dithiane ring, pyran ring, dihydropyran Ring,
- a fully saturated 418-membered heterocyclic group derived by removing one hydrogen atom more preferably a pyrrolidine-111-yl group, an azetidine-1-yl group, and a thiomorpholine- 4 group.
- the “0-membered heteroaryl ring group” means a monovalent group obtained by removing one hydrogen atom at an arbitrary position from the following “5-10-membered heteroaryl ring”.
- the above “5- to 10-membered heteroaryl ring” does not have 5 atoms in the ring And an aromatic ring containing one or more heteroatoms among the atoms constituting the ring (in the case of a condensed ring, at least one of the rings needs to have an aromatic; ⁇ property).
- Means for example, pyridine ring, thiophene ring, furan ring, pyrrole ring, oxazole ring, isoxazole ring, thiazole ring, thiadiazole ring, isothiazole ring, imidazole ring, triazole ring, tetrazole ring, pyrazole ring, furazane ring, Thiadizazole ring, oxaziazonole ring, pyridazine ring, pyrimidine ring, pyrazine ring, triazine ring, indozole ring, isoindonole ring, indazoinole ring, quinoline ring, isoquinoline ring, cinnoline ring, quinazoline ring, quinoxaline , Naphthyridine ring, phthalazine ring, purine ring, pteridine ring, Nofuran ring
- Preferred as the “5-10 membered heteroaryl ring group” are A 6-membered group, more preferably an isoxazole ring group, an oxaziazole ring group, a tetrazole ring group, a pyridine ring group, a thiazonole ring group or a thiophene ring group, and particularly preferably a pyridine ring group or thiazole Ring group, thiophene ring group or tetrazole ring group .
- halogen atom for R 30, R 31 and R 32, the same as those described above can be mentioned, and a fluorine or chlorine atom is preferable.
- Examples of the “C 16 alkyl group” for R 30, 131 and 132 include, for example, the same ones as described above, preferably those of C 14 And particularly preferably a methyl group.
- Examples of the “C 1-6 alkoxy group” of R 30, B 31 and R 32 include, for example,
- C 1-4 Particularly preferred is a methoxy group.
- the “C 2-7 alkoxycarbonyl group” of R 30, R 31 and R 32 means a carbonyl group to which the above-mentioned “C 1-6 alkoxy group” is bonded, for example, Methoxycanoleponinole, ethoxycanoleboninole, propoxycanoleponinole, isop orchid poxcanoleponinole, butoxycanoleboninole, isobutoxycanoleponyl, s-butoxycarbonylinole, t-butoxycarbonyl / pentoxy, pentoxycarbonyl , Isopentoxy power / reponii / re, 2-methinolevbutoxycanoleponinole, neopentoxycarboninole, hexyloxy power / reponyl, 4-methylpentoxycanoleponyl, 3-methylpentoxycarbonyl, 2-methylpentoxycarbonyl, 3,3-dimethylbutoxycanolepon
- straight-chain or branched ones such as 1,1,2-dimethynolebutoxycanoleponinole, 1,3-dimethylbutoxycarbonyl and 2,3-dimethylbutoxycarbonyl groups.
- Examples of the “C 1-10 alkyl group” of the “C 1-10 alkyl group optionally having substituent (s) selected from the following D 1 group” of R 40 include, for example, the aforementioned C 1 -In addition to those exemplified for the 6 alkyl group, there may be mentioned C7-C10 straight-chain or branched-chain alkyl groups such as heptyl, 3-methylhexyl, lactocinole, noel and decyl. Suitably, it is of C16, particularly preferably a methyl, ethyl, propyl, isopropyl, isopropyl, butyl or pentyl group.
- Examples of the “3-8 membered cycloalkyl group” of the “3-8 membered cycloalkyl group which may have a substituent selected from the following E 1 group” of R 40 include, for example, Propinole, cyclobutynole, cyclopentinole, cyclohexyl ', cycloheptinol or cyclooctyl group, preferably cyclopropyl, cyclobutyl, cyclopentyl, cyclopentyl, cyclohexyl or cycloheptyl group And particularly preferably a cyclobutyl, a pentynole or a hexyl group.
- the “C 2-7 alkenyl group” of the “C 2-7 alkenyl group optionally having substituent (s) selected from the following F 1 group” of R 40 is one to two double bonds. It means a linear or branched alkenyl group having 2 to 7 carbon atoms which may be contained, for example, ethyl, 1-propenyl, 2-propenyl, 1-butenanol , 2-butenyl, 3-buteninole, 2-methyl-2-propeninole, 2-methyl-1-propeninole, 1-pentenyl, 1-hexeninole, 1,6-hexanenyl or Examples thereof include a 1-heptenyl group and the like, preferably a C2-15 group, and particularly preferably a 2-propyl group or a 2-methyl-2-propyl group.
- the “C 2-7 alkynyl group” of the “C 2-7 alkyl group optionally having a substituent selected from the following F 1 group” of R 40 includes 1 to 2 triple bonds
- Means a linear or branched alkynyl group having 2 to 7 carbon atoms which may be, for example, ethininole, 1-propyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, Examples thereof include 1-pentinole, 1-hexinole, 1,6-hexanedininole and 1-heptyl group, preferably C 2-5, and particularly preferably 2-butynyl. Or 2—a propyl group.
- Examples of the “C 2-7 alkylcarbonyl group” of the C 2-7 alkylcarbonyl group J which may have a substituent selected from the following G 1 of R 40 include, for example, those described above. The same may be mentioned, preferably C 2-5, and particularly preferably acetyl or propylpyruponyl group.
- the “mono (C 1-6 alkynole) aminocarbonyl group” of R 40 above means a carbonyl group to which the above-mentioned “mono (C 1-6 alkyl) amino group” is bonded. , Methylaminocarbonyl, ethylaminocarbonyl, propylamino Carbonyl, isopropylaminocarbonyl, butylaminocarbonyl, isobutylaminocarbonyl, S-butynoleaminocarbonyl, .t-butylaminocarbonyl
- Pentylaminocarbinole Isopenpentinoaminocarbonyl, 2-Methylbutylaminocarboel, Neopentylaminocarbonyl, 1-Ethylpropylaminopropyl, Hexylaminopropyl, Isohexylaminocarbonyl , 4-methylpentylaminocarbonyl, 3-methylinopentaminoaminocarbinole, 2-methylpentylaminocarbonyl, 1-methylpentylaminocarbonyl, 3,3-dimethylpentylaminocarbonyl, 2, 2-Dimethyl / L-butylaminocarbonyl, 1,1-Dimethynolebutylamino-carbonyl, 1,2-Dimethinolevbutino-amino-canolepod, 1,3-Dimethylbutylaminocarbonyl , 2,3-dimethylbutylaminocarbonyl, 1-ethylbutyl,
- the “418-membered heterocyclic carbonyl group” of R 40 means a carboyl group to which the above-mentioned “418-membered heterocyclic group” is bonded, preferably piperidine. It is a 1-ylcarbonyl or a morpholine-14-ylcarbonyl group.
- C 2-7 alkoxycarboyl group for example, those similar to the aforementioned groups can be mentioned, and a methoxycarbonyl or ethoxycarbyl group is preferable.
- the “C 16 alkylsulfonyl group” of the above R 40 means a sulfonyl group to which the above-mentioned “C 16 alkyl group” is bonded, and includes, for example, methylsulfonyl, ethynolesnoreh Nil, propisolesulfonnole, isopropinolesnorrenhonole, carbonyl butinolesnorhonole, isobutinolesulfononole, s-butizolesolehoninole, t-butinolesnorenolinole, pentylsnorenorenole, pentylshorenorenore, iso Pentinores reno honoré, 2-methinolebutinores honoré, neopentino resnoré honoré, 1-etchinoles propinores honoré, hexinores reno honoré, hexinoles reno honor
- halogen atom in the above group A1 include the same ones as described above, and are preferably a bromine, fluorine or chlorine atom.
- Examples of the “C 16 alkoxy group” in the group A 1 include the same ones as described above, preferably C 1-4, and particularly preferably a methoxy group. It is.
- Examples of the “C 16 alkyl group” of the above-mentioned group A 1 and the following group A 2 include the same as those described above, preferably C 14, and particularly preferably Are methinoles, ethinoles, n-butinoles or t-butinoles.
- the “C 1-6 haloalkyl group” in the above-mentioned A 1 group and the following A 2 group means the above-mentioned “C 1-6 alkyl group” in which 1 to 6 above-mentioned “halogen atoms” are bonded.
- C 2-7 alkylene group of the above-mentioned A 1 group and the following A 2 group (provided that spiro is combined with a substituted 5- to 10-membered cycloalkyl group or a substituted 5- to 10-membered cycloalkenyl group)
- a bond is produced
- straight or branched chains such as 1,2-ethylene, trimethylene, propylene, ethynoleethylene, tetramethylene, pentamethylene, hexamethylene or heptamethylene groups.
- halogen atom examples include the same ones as described above, and are preferably a fluorine or chlorine atom.
- Examples of the “C 2-7 alkoxycarbyl group” in the above group B1 include the same ones as described above, preferably a methoxycarbol or ethoxycarbonyl group.
- halogen atom examples include the same ones as described above, and are preferably a bromine, fluorine, or chlorine atom.
- Examples of the “C 16 alkyl group” of the above-mentioned C 1 group and the following C 2 group include the same as those described above, preferably C 14, and particularly preferably. Suitably, it is a methyl group.
- C 1-6 alkoxy group examples include, for example, the same ones as described above, preferably those of C 1-4, Preferably it is a methoxy, ethoxy or isopropoxy group.
- Examples of the “halogen atom” in the above-mentioned group D1 and the following group D2 include, for example, the same ones as described above, and are preferably a fluorine or chlorine atom.
- Examples of the “C 1-6 alkoxy group” in the above-mentioned group D 1 and the following group D 2 include the same ones as described above, preferably C 1-4, and particularly preferably Is a methoxy or ethoxy group.
- the “C 1-6 alkylthio group” in the above D 1 group means a thio group to which the above-mentioned “C 1-6 alkyl group” is bonded, for example, methylthio, ethinorethio, propylthio, isopropylthio, Carboerptylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio, isopentylthio, 2-methylinolebutinorethio, neopentylthio, 1-ethylpropylthio, hexylthio, isohexylthio, 4 —Methylpentylthio, 3-methylpentinothio, 2-methylpentylthio, 1-methylpentylthio, 3,3-dimethylbutylthio, 2,2-dimethylbutylthio, 1,1-dimethylbutylthio,
- Examples of the “C 16 alkylsulfonyl group” of the above-mentioned D 1 include the same as those described above, preferably C 14, and particularly preferably methyl. Noresulfonyl or ethylsulfonyl group.
- the “C 1-6 alkylsulfinyl group” in the above-mentioned D 1 means a sulfinyl group to which the above-mentioned “C 1-6 alkyl group” is bonded, and includes, for example, Fininole, Propinoresnolenoenole, Isopropinolesnorefineinole, Canoleboninolebutinoreszolefinil, Isobutylsnolenoiele, s-butylsulfinolenole, t-butinoresnolefinil, pliers Noresnorefinore, Isopentinoresnorefinole, 2-Methinolebutinoresorefininole, Neopentinoresnorefinyl, 1-ethinole Propinoresnorefinore, Hexylsulfini Nore, Isohexinores norefinore, 41-Meth
- Examples of the “mono (C 1-6 alkyl) amino group” in the D1 group include the same as those described above, preferably a methylamino or ethylamino group, and particularly preferably It is a methylamino group.
- Examples of the “di (C 1-6 alkyl) amino group” in the above group D1 include the same ones as described above, preferably a dimethylamino, methylethylamino or getylamino group, and particularly preferably. Is a dimethylamino group.
- the “C 2-7 alkylcarbonylamino group” in the above D1 group means an amino group to which the above-mentioned “C 2-7 alkylcarbonyl group” is bonded, for example, acetylamino, acetylamino, Tylcarbonylamino, n-propylcarbonylamino, isopyl pillonylamino, n_butylcarbonylamino, isobutylcarbonylamino, s-butylcarbonylamino, t-butylcarbonylamino, pentylcarbonylamino, Isopentylcarbonylamino, 2-methylbutylcarbonylamino, neopentylcarbonylamino, 1-ethylpropylcarbonylamino, hexylcarbonylcarbonyl, isohexylcarbonylamino, 4-methylpentyl Carbonylamino, 3-methylpentinole amino, 2-methylp
- ⁇ 8-membered cycloalkyl group '' for example, the same as those described above can be mentioned, preferably a cyclopropinole, cycloptynole, cyclopentyl or cyclohexyl group, more preferably cyclopropyl or cyclohexyl It is a mouth butyl group, most preferably a cyclopropyl group.
- Examples of the “C 2-7 alkoxycarbonyl group” in the group D1 include the same ones as described above, and are preferably a methoxycarbonyl or ethoxycanoleponinole group.
- Examples of the ⁇ 4- to 8-membered heterocyclic group '' of the above-mentioned group D1 and the following group D2 include, for example, the same ones as described above, preferably a tetrahydrobiran ring group or a tetrahydrofuran ring group. And particularly preferably a tetrahydropyran-4-yl group.
- Examples of the “5- to 10-membered heteroaryl ring group” in the above-mentioned D1 include the same ones as described above, and are preferably furyl, chenyl, pyridyl, virazyl, pyrimidinyl or pyridaziel. And particularly preferably a furyl, phenyl or pyridyl group.
- the “6- 10-membered aryl group” of the above-mentioned D 1 is an aromatic hydrocarbon cyclic group having 6 to 10 carbon atoms (in the case of a condensed ring, at least one of the rings shows aromaticity).
- the “C 2-7 alkylcarboyl group” in the above group D 1 and the following group D 2 is, for example, And the same as those described above, preferably C 2-5, and particularly preferably an acetyl or ethylcarbonyl group.
- the “6-10 membered arylyl carbonyl group” in the above D1 group means a carbonyl group to which the aforementioned “6-10 membered arylene ring group” is bonded, for example, benzoyl, 1 Examples include mono-naphthoinole, 2-naphthoyl, indenylcarboxyl, indanino-le-carboninole, azulenylcarbonyl or heptalenylcarbonyl group, and preferably benzoyl, 1-naphthoyl or 2-naphthoyl group, and particularly preferably. Is a benzoinole group.
- the “mono (C 1-6 alkyl) aminocarboyl group” those similar to the aforementioned ones can be mentioned, and it is preferably one having a total of C 2-5 carbon atoms, more preferably Methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, isopropylaminocarbonyl or butylaminocarbonyl, most preferably methylaminocarboyl, ethylaminocarbonyl, propyl An aminocarbonyl or isopropylaminocarboyl group.
- Examples of the “mono (3-8 membered cycloalkyl) aminocarbonyl group” in the above-mentioned D1 include cyclopropylaminocarbonyl, cyclobutylaminocarbonyl, pentylaminocarbonyl, cyclohexylaminocarbonyl, cyclohexylaminocarbonyl, Mention may be made of heptylaminocarbonyl or cyclooctylaminocarboxy groups, preferably propylaminocarbonyl, butylaminocarbonyl, cyclopentylaminocarbonyl or hexaminoaminocarbonyl. And particularly preferably a cyclopropylaminocarbonyl group.
- the “mono (C 2-7 alkoxyalkyl) aminocarbonyl group” of the above-mentioned D 1 means that it is an amino group to which a “C 2-7 alkoxyalkyl group” is bonded.
- C 2-7 alkoxyalkyl group means in the range of C 2-7, It means that the above-mentioned “C 1-6 alkoxy group” is bonded to the above-mentioned “C 1-6 alkyl group”.
- Examples of the “mono (C 2-7 alkoxyalkyl) aminocarbonyl group” include, for example, methoxymethylaminocarbonyl, methoxethylaminocanoleponin, ethoxyhexylaminocarbonyl, methoxypropylamino Examples include a minocarbonyl or propoxyshetylaminocarbonyl group, and a methoxyethylaminocarbonyl group is preferable.
- the “di (C 1-6 alkyl) aminocarbonyl group” in the above-mentioned group D 1 and group D 2 below means a carbonyl group to which the above-mentioned “di (C 1-6 alkyl) amino” is bonded.
- dimethylaminocarbonyl methylethylaminocarbonyl, dimethylaminocarbonyl, methylpropylaminocarbonyl, ethylpropylaminocanoleboninole, dipropylaminocanoleponyl, diisopropylaminocanoleponyl
- dibutinoreaminocanolebonyl disobutinoreaminocanolebon / re
- di (s-petit / re) aminocanoleponyl di (t-butyl) aminocarbonyl, methylpentylaminocanolebonole, di Pentinole Amino Canole Ponore, Diso Pentinole Amino Power / Repo Ninole, Di (2-Methinolebutinole) Canoleboninole, di (neopentinole) aminocanoleponinole, di (1-ethylpropyl) aminocarbonyl
- the “mono (5- to 10-membered heteroaryl II) aminocarbonyl group” in the above-mentioned D1 group means that one of the hydrogen atoms of the amino-carbonyl group (l-bamoyl group) is converted to the above-mentioned “5- to 10-membered group”.
- 5- to 10-membered heteroaryl ring means, for example, a pyridine ring, a thiophene ring, a furan ring, a pyrroyl ring, an oxazole ring, an isoxazole ring, Thiazole ring, thiadiazole ring, isotiazole ring, imidazonole ring, triazonole ring, tetrazole ring, villazole ring, furazane ring, thiadiazole ring, oxaziazole ring, pyridazine ring, pyrimidine ring, pyrazine ring, triazine ring, indole ring, isindole ring , Indazole ring, quinoline ring, isoquinoline ring, cinnoline ring, quinazo Ring, quinoxaline ring, naphthyridine ring, phthalazin
- the “4-8-membered heterocyclic carbonyl group” of the “4- to 8-membered heterocyclic carbonyl group which may be substituted with a C1-6 alkyl group” of the above-mentioned D1 group and the “4- Examples of the “8-membered heterocyclic carbonyl group” include the same as those described above, preferably pyrrolidine-1-ylcarbonyl, azepan-1-ylcarbonyl, azocan-1-ylcarbonyl, piperidine-1-ylcarbonyl. Or a morpholin-4-ylcarbonyl group, particularly preferably a pyrrolidine-1-ylcarbonyl, piperidine-11-ylcarbonyl or morpholin-4-ylcarbonyl group. .
- the “5- to 10-membered heteroaryl ring carbonyl group” of the above-mentioned D 1 group refers to the aforementioned “5- A 10-membered heteroaryl ring group "is a bonded carbonyl group.
- the “5-membered heteroaryl ring group” in Group D2 below refers to the “5- to 10-membered heteroaryl ring group” described above in which the number of atoms constituting the ring is 5, for example, Chenyl, furyl, pyrrolyl, oxazolinole, isoxoxazolyl, thiazolyl, thiadiazolinole, isothiazolyl, imidazolyl, triazolyl, pyrazolyl, furazanil, oxaziazolyl, and the like, and preferably phenyl or furyl.
- halogen atom examples include the same ones as described above, and are preferably a bromine, fluorine, or chlorine atom.
- Examples of the “C 1-6 alkoxy group” in the group E1 include the same ones as described above, preferably C 1-4, and particularly preferably methoxy. Group.
- Examples of the “C 16 alkyl group” in the above-mentioned E 1 group include the same ones as described above, preferably C 1-4, and particularly preferably a methyl group. is there.
- halogen atom in Group F1 include the same ones as described above, and are preferably a fluorine or chlorine atom.
- Examples of the “C 1-6 alkoxy group” in the above-mentioned F 1 include the same ones as described above, preferably C 1 -4, and particularly preferably methoxy. Group.
- Examples of the “3-8-membered cycloalkyl group” in Group G1 include the same ones as described above, and particularly preferably a cyclohexyl or cyclopropynole group. [0 0 2 3]
- Examples of the “C 1-6 haloalkyl group” in the above-mentioned HI group include the same ones as described above, and particularly preferably a chloromethyl or fluoromethyl group.
- Examples of the “C 16 alkyl group” in the HI group include the same ones as described above, preferably C 14, and particularly preferably a methyl group. .
- Examples of the “C 2-7 alkoxyalkyl group” in the above HI group include the same ones as described above, and are preferably a methoxymethyl group.
- Examples of the “mono (C 1-6 alkyl) aminocarbonyl group” in the above HI group include the same ones as described above, and preferably include a methylaminocarbonyl group.
- Examples of the “di (C 16 alkyl) aminocarbonyl group” in the above HI group include the same ones as described above, and preferably a dimethylaminophenol or acetylaminocarbonyl group. , And particularly preferably a dimethylaminopropyl group.
- Examples of the “C 2 _ 7 alkoxycarbonyl group” in the above HI group include the same ones as described above, and are preferably methoxycarboel or ethoxycanolevonyl group.
- the “C 2-7 cyanoalkyl group” of the above HI group is the above-mentioned cyano group-bonded
- C1-6 alkyl group means, for example, methyl, ethyl, n-propynole, isopropinole, n-petitinole, isoptinole, s-butyl, t-butyl, pentynole, '.isopentinole, 2-methinolebutinole, neopentyl, 1-ethynolepropynole, hexinole, isohexinole, 4-methizolepenty / re, 3-methinolepentinole, 2-methizolepentyl, 1-methylpentyl, 3,3-dimethinolebutyl, 2 , 2-dimethylbutyl,
- the structural formula of a compound may represent a certain isomer for convenience, but in the present invention, all geometric isomers occurring in the structure of the compound, optical isomers based on asymmetric carbon, It includes isomers such as stereoisomers and tautomers and isomer mixtures, and is not limited to the description of the formula for convenience, and may be either one isomer or a mixture. Accordingly, the compound of the present invention may have an asymmetric carbon atom in the molecule, and may exist in an optically active form and a racemic form. However, the present invention is not limited thereto, and includes both. .
- polymorphism may exist, but is not limited thereto, and may be a single substance or a mixture of any one of the crystal forms. And hydrates.
- the present invention also includes so-called metabolites, which are generated by decomposing the compounds (1) and (100) according to the present invention in vivo.
- the compounds (so-called prodrugs) which produce the compounds (1) and (100) of the present invention by metabolism such as oxidation, reduction, hydrolysis and conjugation in a living body are also included in the present invention.
- the “salt” in the present specification is not particularly limited as long as it forms a salt with the compound of the present invention and is pharmacologically acceptable.
- inorganic salts organic acid salts, inorganic salts Base salts, organic base salts, acidic or basic amino acid salts and the like can be mentioned.
- Preferred examples of the inorganic acid salt include, for example, hydrochloride, hydrobromide, sulfate, nitrate, and phosphate
- preferred examples of the organic acid salt include, for example, acetate.
- the inorganic base salt include, for example, sodium salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts, sodium salts and ammonium salts, and the like.
- Preferred examples of the organic base salt include getylamine, diethanolamine, meglumine, and NT, N, dibenzylethylenediamine.
- Preferred examples of the acidic amino acid salt include, for example, aspartate and glutamate.
- Preferred examples of the basic amino acid salt include, for example, arginine, lysine and ordinine salts.
- preferred compounds include the following.
- R 10 may have a substituent selected from the following A2 group, or may have a substituent selected from the following A2 group.
- RIO may be substituted with a hydroxyl group, a phenyl group, a C16 alkyl group, a C16 haloalkyl group, a 1,2-ethylene group, a trimethylene group, a tetramethylene group or a pentamethylene group.
- the substituent is a 1,2-ethylene group, a trimethylene group, a tetramethylene group or a pentamethylene group, a substituted 5- to 10-membered cycloalkyl group or a substituted 5- to 10-membered cycloalkenyl group Only when spiro bond is formed by combining with
- R 10 is a cyclohexyl group, a 4-t-butylcyclohexyl group, a 4,4-dimethylcyclohexyl group, a 4,4-dimethylcyclohexyl group, 3,3
- s represents an integer of 0, 1, 2, or 3
- s represents an integer of 0, 1, 2, or 3
- (4-2) 1 ⁇ 10-41-butynolecyclohexyl group, or a salt thereof, or a hydrate thereof.
- R 10 is 3,3,5,5-tetramethylcyclohexyl group Or a compound or a salt thereof or a hydrate thereof.
- R 10 force 4 Compounds that are 4-trifluoromethylcyclohexyl groups ⁇ ! Is a salt or a hydrate thereof.
- R 10 is a 4-n-butylcyclohexyl group, or a hydrate thereof.
- R 10 force A compound or a salt thereof, or a hydrate thereof, which is a cyclopentyl group.
- R 1 C ⁇ S a cycloheptyl group, a compound or a salt thereof, or a hydrate thereof.
- s represents an integer of 0, 1, 2, or 3
- s represents an integer of 0, 1, 2, or 3
- R 10 is the formula
- R 10 is the formula
- s represents an integer of 0, 1, 2, or 3
- s represents an integer of 0, 1, 2, or 3
- R 10 is the formula
- R 10 is the formula
- R20, R21, 122 and 123 same or different hydrogen atom, hydroxyl group, halogen atom, cyano group, C2-7 alkylcarbonyl group, nitro group, amino group A mono (C 1-6 alkyl) amino group, a di (C 1-6 alkyl) amino group, a C 16 alkyl group which may have a substituent selected from the above group B 1, A C 16 alkoxy group which may have a substituent selected from group 1; a 4- to 8-membered heterocyclic group or a group which may have a substituent selected from the group C 1 A compound or a salt thereof, or a hydrate thereof, which is a 5- to 6-membered heterocyclic group which may have a substituent selected from the above-mentioned group C1.
- R 20, R 21, R 22 and R 23 same or different, hydrogen atom, hydroxyl group, halogen atom, cyano group, acetyl group, nitro group, amino group, monomethylamino group, monoethylamino group, dimethylamino group,
- a C 16 alkyl group optionally having a substituent selected from the group B 1, a C 1-6 alkoxy group optionally having a substituent selected from the group B 1,
- C A 4- to 8-membered heterocyclic group which may have a substituent selected from Group 1 (however, a group derived by removing a hydrogen atom bonded to a nitrogen atom of the 4- to 8-membered heterocyclic ring) Or a 5- to 6-membered heteroaryl ring group optionally having a substituent selected from the following group C 2, or a salt thereof or a hydrate thereof.
- R 20, R 21, R 22 and R 23 Identical or different, hydrogen atom, halogen atom, cyano group, acetyl group, monomethylamino group, monoethylamino group, dimethylamino group, methyl group, methoxy Group, ethoxy group, morpholine-14-yl group optionally having a substituent selected from the above-mentioned group C2, and piperidine optionally having a substituent selected from the above-mentioned group C2 1-yl group, above C 2 group
- At least two of R 20, R 21, R 22, and R 23 are hydrogen atoms, and the remainder is the same or different and is a hydrogen atom, a halogen atom, a cyano group, or an acetyl group.
- a piperidine-11-yl group optionally having a substituent selected, a pyrrolidine-11-yl group optionally having a substituent selected from the group C2, and an azetidine-11-yl group
- the other one is a hydrogen atom, a fluorine atom, a cyano group, a dimethylamino group, a methyl group, a methoxy group, a morpholin-4-yl group which may have a substituent selected from the following group C3, A piperidin-1-yl group optionally having a substituent selected from the following C3 group or a pyrrolidine-1-yl group optionally having a substituent selected from the following C3 group: Or a compound or a salt thereof or a hydrate thereof.
- R20, R21, R22 and R23 are hydrogen atoms, and the other one is a morpholine which may have a substituent selected from the following group C3. 4-yl compound, its salt or hydrate thereof.
- At least three of R20, R21, R22 and R23 are hydrogen atoms, and the other one has a substituent selected from the following C3 group A compound or a salt thereof, or a hydrate thereof, which is a piperidine-11-yl group;
- At least three of R20, R21, R22 and R23 are hydrogen atoms, and the other one has a substituent selected from the following C3 group A compound or a salt thereof or a hydrate thereof, which is a good pyrrolidine-11-yl group.
- R30, R31 and R32 are the same or different and each represent a hydrogen atom or a methyl group, or R30 and R31 together form an oxo group
- R 32 is a hydrogen atom or a methyl group, wherein R 32 is a hydrogen atom or a methyl group, or a salt or hydrate thereof.
- R40 may have a substituent selected from the above-mentioned D1 group, and may have a substituent selected from the above-mentioned E1 group.
- 140 is 11-propyl group, n-butyl group, n-pentyl group, isobutyl group, ethylcarbinolemethyl group, methoxeti / re group, ethoxyxetyl group, cyclopropylmethyl group or tetrahydropyran.
- R40 force A compound, salt or hydrate thereof, which is a butyl group.
- R 10 is a cyclohexyl group optionally having a substituent selected from the following A1 ′ group or a cyclohexene group optionally having a substituent selected from the following A1 ′ group: Indicates a group,
- R 20, R 21, R 22 and R 23 ⁇ ; the same or different, a hydrogen atom, a hydroxyl group, a halogen atom, a cyano group, a nitro group, an amino group, a mono (C 16 alkyl) amino group, (C 1-6 alkyl) an amino group, which may have a substituent selected from the following B 1 ′ group, and a C 16 alkyl group, which has a substituent selected from the following B 1 ′ group A C.1-6 alkoxy group, an optionally substituted 418-membered heterocyclic group or a substituent selected from the following C 1 ′ group, which may have a substituent selected from the C 1 ′ group.
- R30, R31 and R32 are the same or different, and each represents a hydrogen atom, a hydroxyl group, a nitrogen atom, a cyano group, a carboxyl group, a C16-anolealkyl group, a C16-alkoxy group or a C2-7-alkoxycarbo group; Represents a di group, or
- R40 represents a C 1-10 alkyl group or a 3-8 membered cycloalkyl group which may have a substituent selected from the following D 1 ′ group,
- n an integer of 1 or 2
- XI represents a CH group or a nitrogen atom.
- XI represents a salt thereof or a hydrate thereof.
- R10 may have a substituent selected from the following group A2, group A hexyl group or a group optionally having a substituent selected from group A2 'below 101.
- the compound according to ⁇ 101> which is a hexenyl group, a salt thereof, or a hydrate thereof.
- ' A2 'group> C1_6 alkyl group and C2-7 alkylene group (provided that a spiro bond occurs together with the substituted cyclohexyl group or cyclohexenyl group).
- ⁇ 103> a cyclohexyl group or a C1-6 alkyl group in which R10 may be substituted by a C1-6 alkyl group, a 1,2-ethylene group, a trimethylene group, a tetramethylene group or a pentamethylene group
- R10 may be substituted by a C1-6 alkyl group, a 1,2-ethylene group, a trimethylene group, a tetramethylene group or a pentamethylene group
- the substituent is a 1,2-ethylene group, trimethylene group, tetramethylene group or pentamethylene group
- the spiro bond is formed together with the substituted hexyl group or the substituted hexenyl group. Only when it occurs.
- R 10 force hexahexyl group, 4- (t-butyl) cyclohexyl group, 4,4-dimethyl'hexyl group, 4,4-1, hexyl hexyl group, 3,3,5 , 5-tetramethylcyclohexyl group, formula
- s represents an integer of 0 to 3.
- the compound described in ⁇ 101> or a salt thereof is a hydrate thereof.
- R20, R21, R22 and R23 force same or different, hydrogen atom, halogen atom, cyano group, amino group, mono (C1-6 alkyl) amino group, Di (C 1-6 alkyl) amino group, C 1-6 alkyl group optionally substituted by fluorine atom, C 16 alkoxy group optionally substituted by fluorine atom, or the following C 2 ′ group
- the compound according to ⁇ 101> ⁇ 104> which is a 4- to 8-membered heterocyclic group optionally having substituent (s), a salt thereof, or a hydrate thereof.
- R20, R21, R22 and R23 force same or different, hydrogen atom, halogen atom, cyano group, amino group, monomethylamino group, dimethylamino group, methyl group, methoxy group, C2 below
- a morpholino group optionally having a substituent selected from the group C or a pyridino group optionally having a substituent selected from the following C2 'group. Or a salt thereof or a hydrate thereof.
- ⁇ C 2 ′ group > C 1-6 alkoxy group and C 1-6 alkyl group.
- At least three of R20, R21, R22 and R23 are hydrogen atoms, and the other one is a hydrogen atom, a halogen atom, a methoxy group or a cyano group.
- 104 The compound according to the above, or a salt thereof or a hydrate thereof.
- R30, R31 and R32 are the same or different and each represent a hydrogen atom or a methyl group, or R30 and R31 together represent an oxo group (formula O group); 101> to 107>, wherein 32 is a hydrogen atom or a methyl group, or a salt or hydrate thereof.
- R30, R31 and R32 are all hydrogen atoms, or a salt thereof or a hydrate thereof.
- R40 is a C16 alkyl group which may have a substituent selected from the following D2, a group, or a compound or a salt thereof according to 101> to 110> Are their hydrates.
- D2 group> C 1-6 alkoxy group, 3-8 membered cycloalkynole group, 4-8 membered heterocyclic group, cyano group, mono (C 1-6 anoalkyl) aminocarbinole group, C 2-7 alkyl A carbonyl group and a 4- to 8-membered heterocyclic carbonyl group.
- R 40 may have a substituent selected from the group consisting of D 3 and C 3 below.
- R40 is an n-propyl group, an n-butyl group, an n-pentyl group, an ethylcaprolmethyl group, a methoxyxethyl group, an ethoxyxyl group, a cyclopropylmethyl group or a 4-tetrahydropyraelmethyl group.
- 101> The compound according to ⁇ 10>, a salt thereof, or a hydrate thereof.
- n is an integer of 1, or a salt or hydrate thereof.
- ⁇ 115> The compound according to any one of ⁇ 101> to ⁇ 114>, wherein XI is a nitrogen atom, or a salt or hydrate thereof.
- a cell adhesion inhibitor or a cell invasion inhibitor comprising the compound of ⁇ 1.18> ⁇ 101>, a salt thereof, or a hydrate thereof.
- Inflammatory bowel disease rheumatoid arthritis, psoriasis, multiple sclerosis, asthma or atopic disease, containing the compound of ⁇ 11 9> ⁇ 101> or a salt or hydrate thereof Agent for treating or preventing dermatitis.
- a compound for treating or preventing inflammatory bowel disease comprising the compound of ⁇ 101> or a salt thereof, or a hydrate thereof.
- An agent for treating or preventing ulcerative colitis or Crohn's disease comprising the compound of ⁇ 121> ⁇ 101> or a salt thereof or a hydrate thereof.
- the compound of the present invention has an excellent cell adhesion inhibitory action or cell infiltration inhibitory action, it is particularly useful as a therapeutic or preventive agent for inflammatory diseases and autoimmune diseases, especially for inflammatory bowel diseases (particularly ulcerative colitis or Crohn's disease). ), Irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma or atopic dermatitis, and is useful as a therapeutic or prophylactic agent for various diseases caused by leukocyte adhesion and infiltration.
- Compound (1) of the present invention and compound (100) of the present invention can be produced by the methods described below. However, the method for producing the compound of the present invention is not limited thereto.
- the compound (1) of the present invention can be produced by the following Method A, Method B, Method C, Method D, Method E, Method N, Method P or Method V.
- the f-conjugated compound (1A) wherein X 1 is a nitrogen atom can be produced by the following F method, G method, H method, K method, M method, Q method or R method. can do.
- the compound (1B) and the compound (100) of the present invention in which X 1 is a CH group are represented by the following methods A, B, C, D, and E , K method, M method, S method, T method or U method.
- Method A is a method in which an alkylating agent (3) or a carboery ligating agent (3) is added to compound (2) in an inert solvent in the presence or absence of a base, in the presence of an additive "
- a method for producing the compound (1) of the present invention by reacting the sulfonylating agent (3) and removing a protecting group of the obtained compound as required, or a method comprising reacting the compound (200) Then, the same reaction as described above is carried out to produce the compound (100) of the present invention.
- R 31, R 32, R 40, X 1 and n are as defined above, RIO a, R 20 a, R 21 a, R 22 a, R 23 a, R 30 a, R 31 a, R_32a and R40a are each a force having the same meaning as R10, R20, R21, R22, R23, R30, R31, R32 and R40, or each group R 10, R 20, R 21, R 22, R 23, R 30, R 31, where the overlying substituent is protected
- R 32 and R 4 are each a group, Wl represents a so-called leaving group, a chlorine atom, a bromine atom or an iodine atom, or an alkylsulfonyloxy group such as methanesnolephonyloxy, ethanesulfoninoleoxy group, etc.
- Haloalkane snoryloxy groups such as trifluoromethanebutanol sulfonyloxy group, nonafluorobutanesulfonyloxy group or arylsulfonyloxy group such as benzenesulfonyloxy and paratoluenesulfoninoleoxy group And preferably a chlorine atom, a bromine atom, an iodine atom, a methanesulfonyloxy group, a paratoluenesulfonyloxy group, a nonaf / leolobutanesulfoninoleoxy group or a trifluoromethanesnolehoninole group. It is a xy group.
- the solvent to be used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction of the present invention to the extent of: ::, specifically, formamide, dimethylformamide, dimethyl Amides such as acetoamide, hexamethylphosphate triamide, N-methylpyrrolidone, nitriles such as acetonitrile, isobutyronitrile, aromatic hydrocarbons such as toluene, benzene, xylene or getyl Ether, diisopropyl ether, tetrahydrofuran, dioki Examples thereof include ethers such as sun, dimethoxetane, and diethylene glycolone methinole ether, sulfoxides such as dimethyl sulfoxide, and a mixture of these solvents.
- dimethylformamide, acetonitrile, Toluene or tetrahydrofuran is not particularly limited as long as it does not dissolve the starting compound to some extent
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product, but specific examples thereof include triethylamine and pyridine.
- Organic bases or inorganic bases such as potassium carbonate, sodium carbonate, sodium bicarbonate, sodium bicarbonate and cesium carbonate can be mentioned, preferably potassium carbonate or triethylamine.
- sodium iodide or potassium iodide is used as an additive for accelerating the reaction.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 30 to 180 ° C., preferably from 0 to 120 ° C.
- the reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually 0.5 to 100 hours, preferably 0.5 to 24 hours.
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- the solvent is formaldehyde, dichloromethane, 1,2-dichloroethane.
- Halogenated hydrocarbons such as carbon tetrachloride, ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxan, dimethoxetane, diethylene glycolone resin methinolate ether, formamide, dimethylformamide Amides such as amide, dimethylacetamide, hexamethyl phosphate triamide, N-methylpyrrolidone, organic bases such as pyridine, water or a mixture of these solvents.
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product!
- organic bases such as triethylamine and pyridine
- inorganic bases such as potassium carbonate, sodium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, cesium carbonate and sodium hydroxide can be mentioned. And preferably potassium carbonate or triethylamine.
- 4-dimethylaminopyridine is used as an additive to promote the reaction.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from -70 to 120 ° C, preferably from -70 to 60 ° C.
- the reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually 0.5 to 48 hours, preferably 0.5 to 12 hours.
- the compound (1) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1) and the obtained compound (100) is a 5- to 10-membered cycloalkyl group which may have a substituent
- R 10 is obtained by hydrogenation.
- R 10 of the obtained compound (100) may have a substituent.
- compound (1B) of the present invention (compound of formula (1) wherein X 1 is a CH group) can be obtained by hydrogenation. Hydrogenation can be performed as follows.
- a hydrogenation reaction is performed using a metal catalyst in an inert solvent, in a hydrogen gas atmosphere or in the presence of a hydrogen atom donating reagent, in the presence or absence of an acid.
- the solvent used is to dissolve the starting compound to some extent and There is no particular limitation as long as it does not inhibit the reaction, but specific examples include water, alcohols such as methanol, and ethanol, dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycolone resin.
- Ethers such as methinoole ether, methinole acetate, ethinole acetate, propinole acetate, butyl acetate, esters such as getyl carbonate, formamide, dimethylhonolem amide, dimethylacetamide, hexamethyl phosphate triamide
- esters such as getyl carbonate, formamide, dimethylhonolem amide, dimethylacetamide, hexamethyl phosphate triamide
- amides such as N-methinoleviridone, aliphatic hydrocarbons such as hexane, heptane, lignin, and petroleum ether or organic acids such as acetic acid, and a mixed solvent thereof.
- the metal catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- Heterogeneous noble metal catalysts such as palladium, platinum, platinum oxide, rhodium, ruthenium, and eckenole (preferably supported on a carrier such as activated carbon, alumina, silica, and zeolite);
- homogeneous metal complex catalysts such as rhodium (I) (Wilkinson complex), preferably heterogeneous noble metal catalysts (particularly 5 to 5 which may be moistened with water).
- the equivalent of the metal catalyst used (including the carrier) varies depending on the starting materials, solvents and reagents, but is usually 0.05 to 10 times by weight based on the starting materials. 0.05 to 3 times.
- the acid to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product. Specifically, methanesulfonic acid, trifluoromethane Organic acids such as sulfonic acid, acetic acid and trifluoroacetic acid, and inorganic acids such as hydrogen chloride and hydrogen bromide can be mentioned.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 110 to 80 ° C, preferably from 0 to 50 ° C.
- the reaction pressure of hydrogen gas varies depending on the starting material, solvent, and reagent, but is usually 1 to 100 atm, preferably 1 to 5 atm.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.5 to 200 hours, preferably 0.5 to 100 hours.
- the obtained compound when it is desired to use the obtained compound as an acid salt, it can be carried out according to a standard method.
- the step of producing the salt and the step of hydrogenation described above can be carried out in a different order if appropriate.
- R40b is a group suitable for obtaining a desired R40 and having a carboxyl group or a sulfonyl group capable of forming an acid anhydride. The substituent present on R40b may be protected. 'This method can be carried out according to the carbonylation or sulfonylation step of Method A described above.
- the compound (1) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- Method c involves the addition of aldehyde (5) or ketone (5) to compound (2) in an inert solvent, in the presence of a reducing agent, in the presence or absence of an acid, in the presence or absence of an additive. And optionally removing the protecting group of the resulting compound to obtain the compound (1) of the present invention.
- R 10, R 20, R 21, R 22, R 23, R 30, is a method for producing the compound (100) of the present invention.
- R31, R32, R40, X1 and n and R10a, R20a, R21a, R22a, R23a, R30a, R31a and R 32a is synonymous with the above.
- a 1 and A 2 are groups suitable for obtaining a desired R 40.
- the substituent present on A1 or A2 may be protected.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- ethers particularly, tetrahydrofuran
- Haguchigenated hydrocarbons especially dichloroethane
- the reducing agent used is not particularly limited as long as it can obtain the target compound and does not generate an inseparable by-product.
- triacetoxyborohydride examples thereof include boron reducing agents such as sodium, sodium cyanoborohydride, and porane-pyridine, a metal catalyst monohydrogen gas, and the like, and preferably sodium triacetoxyborohydride.
- the acid to be used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product, but specific examples thereof include acetic acid and triacetate.
- Organic acids such as fluoroacetic acid and Lewis acids such as titanium tetraisopropoxide and zinc chloride can be exemplified, and preferred are organic acids (particularly acetic acid).
- the additive used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product.
- Magnesium and the like can be mentioned, and preferred is molecular sieve 4A.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 170 to 120 ° C, preferably from 0 to 50 ° C. '
- the reaction time varies depending on the starting materials, solvent, reagents and reaction temperature, but is usually 0.1 to 2 hours, preferably 0.1 to 24 hours.
- references to supplement the above method include, but are not limited to, Ahmed F. Abdel-Magid et al., J. Org. Chem. (1996), 61, 3849.
- the compound (1) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1) and the obtained compound (100) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the method described in Method A Compound (1) of the present invention or compound (1B) of the present invention, wherein R 10 is a 5- to 10-membered cycloalkyl group optionally having a corresponding substituent (A compound in which X 1 in compound (1) has the formula CH group) can be obtained.
- R 10 of the obtained compound (100) is a 5- to 10-membered cycloalkyl group which may have a substituent
- the compound of the present invention (1B ) (Compound (1) wherein X 1 is a compound of the formula CI-I).
- the obtained compound when desired to be converted to an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step may be carried out in a different order if appropriate. 0 0 5 2
- a method for producing the compound (1) of the present invention by subjecting the resulting compound to a Michael addition reaction and removing the protecting group of the resulting compound as desired.
- a method for producing the compound (100) of the present invention by subjecting the compound (200) to the same reaction as described above.
- R31, R32, R40, X1 and n and R10a, R20a, R21a, R22a, R23a, R30a, R31a and R32a are as defined above. I agree.
- Zl, Z2, Z3 and Z4 are groups suitable for obtaining the desired R40. The substituents present on Zl, Z2, Z3 and Z4 may be protected.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- methanol, ethanol, n-propanol, and isopropanol are used.
- Halogenated hydrocarbons such as propanol, n-butanol, isobutanol, t-butanol, isoamyl alcohol, diethylene glycol, glycerin, phenolic honolems, dichloromethane, 1,2-dichloroethane, carbon tetrachloride, and getyl Ethers such as ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, methylenglycone resin methinoleate, formamide, dimethylformamide, dimethylacetamide, hexamethylphosphate tria Examples thereof include amides such as mid, N-methylpyrrolidone, and aromatic hydrocarbons
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 130 to 150 ° C, preferably from 0 to 120 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.5 to 48 hours, and preferably 0.5 to 24 hours.
- the compound (1) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1) and the obtained compound (100) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the hydrogenation described above during the method A To obtain a compound (1) of the present invention or a compound (1B) of the present invention (compound (1), wherein R 10 is a 5- to 10-membered cycloalkyl group which may have a corresponding substituent.
- X 1 is a compound of the formula CH.
- the compound (1B) of the present invention compound Wherein X 1 in (1) is a compound of the formula CH.
- the obtained compound is desired to be converted to an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step may be carried out in a different order if appropriate.
- method E the compound (2) is reacted with the isocyanate compound (7) or the substituted aminocarboxylide compound (7) in an inert solvent in the presence or absence of a base, and the resulting compound is reacted.
- the method for producing the compound (1) of the present invention by removing the protecting group as desired, or by subjecting the compound (200) to the same reaction as described above to obtain the compound (100) of the present invention It is a method of manufacturing.
- R10, R20, R21, R22, R23, R30, R31, R32, R40, X1 and n and R10a, R20a, R21a, R22a , R23a, R30a, R31a and R32a are as defined above.
- A3, A4 and A5 are groups suitable for obtaining a desired R40. The substituents on A3, A4 and A5 may be protected.
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step. Specifically, chloroform, dichloromethane, and 1,2-dichloromethane are used.
- Methane halogenated hydrocarbons such as carbon tetrachloride, benzene, toluene, aromatic hydrocarbons such as benzene, getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethyloxetane, diethylene glycol dimethy Ethers such as oleether can be mentioned, preferably dichloromethane or tetrahydrofuran.
- the base to be used is not particularly limited as long as the target compound can be obtained and does not produce an inseparable by-product.
- DBU noner 5-ene
- DBU 1-Jazabisik mouth
- DAB CO 1,
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 170 to 100 ° C.
- reaction time varies depending on the starting materials, solvents, reagents, and reaction temperature, but is usually 1 to
- the compound (1) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1) and the obtained compound (100) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the hydrogen described above in the method A may be used.
- the compound (1) of the present invention or the compound (IB) of the present invention (compound (1), wherein R 10 is a 5- to 10-membered cycloalkyl group optionally having a substituent. ))
- X 1 is a compound of the formula CH.
- R 1 ⁇ of the obtained compound (100) is a 5- to 10-membered cycloalkyl group which may have a substituent
- the compound (1B) ( X 1 in compound (1) can be obtained.
- the obtained compound is desired to be converted to an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step may be carried out in a different order if appropriate.
- Method F is performed in an inert solvent, in the presence of a palladium (0) catalyst or copper catalyst, in the presence or absence of a base, in the presence or absence of additives, in an atmosphere of an inert gas or in a non-atmosphere. Then, the compound (8) and the compound (9) are reacted (Amination or Amidation), and the protective group of the obtained compound is optionally removed, whereby the compound (1A) (the above-mentioned formula (1A) 1) wherein X 1 is a nitrogen atom compound).
- R10, R20, R21, R22, R23, R30, R31, R32, R40 and n and R10a, R20a, R21a, R22a, R23a, R30a, R31a And R 3 2.a are as defined above.
- W la represents a chlorine atom, a bromine atom or an iodine atom, or a trifluoromethanesulfonyloxy group.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction of this step.
- dimethylformamide, dimethylacetamide, and Amides such as xamethynolenic triamide, N-methylpyrrolidone, aromatic hydrocarbons such as toluene, benzene, xylene and mesitylene, getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycol Ethers such as dimethyl ether, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, isoaminophenol, diethylene glycol, glycerin, octanol Examples thereof include alcohols such as cyclohexanol, nitriles such as acetonitrile and isobut
- the palladium (0) catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- Power such as tetrakis (triphenylphosphine) palladium, tris (dibenzylideneacetone) dipalladium, bis (dibenzylideneacetone) palladium, bis (tri-t-butylphosphine) palladium, palladium black, etc.
- palladium (0) formed in a reaction system by a combination of various palladium complexes serving as the following palladium (0) precursors and various ligands shown below ) It is a catalyst.
- the various palladium complexes that serve as the palladium (0) precursor, as long as the desired compound can be obtained and an inseparable by-product is not generated.
- the desired compound can be obtained and an inseparable by-product is not generated.
- the ligand is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product.
- the compound is not particularly limited as long as the target compound can be obtained and does not produce an inseparable by-product.
- the additive used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product, but specific examples thereof include lithium fluoride and fluoride.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 0 to 150 ° C, preferably from 20 to 110 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.1 to 100 hours, preferably 0.5 to 48 hours.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- formamide, dimethylformamide, dimethylacetamide Amides such as hexamethylphosphoric triamide, hexamethylinopyrrolidone, aromatic hydrocarbons such as toluene, benzene, xylene, mesitylene, and nitrobenzene, getyl ether, diisopropyl pill ether, tetrahydrofuran, dioxane, dime Ethers such as tokishetan, dethylene glycol dimethyl ether, methanol, ethanol
- ⁇ - propanol isopropanol, ⁇ - ptanol, isobutanol, t Alcohols such as butanol, isomyl alcohol, diethylene glycol, glycerin, octanol, hexanol hexanol and methyl sorb, or a mixture of these solvents, preferably isopropanol,
- the copper catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- copper (powder), Copper chloride (1), copper chloride (11), copper iodide (1), copper oxide (1), copper oxide (II), copper acetate (11), copper sulfate (II) pentahydrate copper Examples include acetyl acetonate (11), copper thiocyanate (I), and the like, preferably copper (powder) and copper chloride (I).
- the ligand is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product.
- ethylene glycol, diethylene glycolose, Cresol, 2,6-dimethynolephenol, 1-naphthol, 21-naphthol, ethylenediamine, N, N'-dimethylethylenediamine, diisopropylamine and the like can be mentioned. Ethylenediamine.
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- sodium t-butoxide, potassium Inorganic bases such as potassium t-butoxide, tripotassium phosphate, trisodium phosphate, cesium carbonate, carbonated carbonate, sodium carbonate, sodium hydride or organic bases such as lithium bis (trimethylsilyl) amide Preferred are potassium carbonate and tripotassium phosphate.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 0 to 250 ° C, preferably from 80 to 150 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.1 to 100 hours, preferably 0.5 to 48 hours.
- Inert reaction When the reaction is carried out in a body atmosphere, there is no particular limitation as long as it does not inhibit the reaction of this step, but specific examples include a / gon or nitrogen gas.
- references supplementing the above method include, but are not limited to, L. Buchwald et al., Org. Lett. (2002), 4, 581.
- the compound (1A) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1A) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 is a 5- to 10-membered cycloalkyl group optionally having a substituent
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- Method G comprises reacting compound (8) with compound (10) in an inert solvent, in the presence of a copper catalyst, in the presence of a base, in the presence or absence of oxygen, to form a protective group on the resulting compound.
- This is a method for producing a compound (1A) of the present invention (a compound in which X 1 in the above formula (1) is a nitrogen atom) by removing the compound as desired.
- Mla is a group represented by the formula —B (OH) 2 .
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- formamide, dimethylformamide, dimethylacetamide Amides such as hexamethylphosphoric triamide, N-methinolepyrrolidone, chlorophonolem, dichloromethane, 1,2-dichloroethane, halogenated hydrocarbons such as carbon tetrachloride, and aromatic hydrocarbons such as toluene, benzene and xylene
- halogenated hydrocarbons such as getyl ether, diisopropyl ether ether, tetrahydrofuran, dioxane, dimethyloxetane, and diethylene glycol dimethyl ether, or a mixture of these solvents.
- halogenated hydrocarbons particularly, dichloromethan ).
- the copper catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate inseparable by-products. Specifically, copper acetate (11) And copper acetate (1), copper trifluoromethanesulfonate (I1), copper isobutylate (II), and the like, and preferably copper acetate (II).
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product, but specific examples thereof include trieti / reamine, pyridine, 2 And organic bases such as 1,6-altidine, N-methyl'monoleforin, or 1,8-diazabicyclo [5.4.0] indene 7-ene, preferably triethylamine or pyridine.
- the additive used for promoting the reaction is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product.
- Molecular sieve, pyridine-N-oxide, or 2,2,6,6-tetramethylpyridinoxy can be mentioned, and preferably, molecular sieve (especially 4A) '.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 0 to 80 ° C, preferably from 10 to 50 ° C. ,
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 100 hours, preferably 24 to 48 hours.
- the compound (1A) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1A) is a 5- to 10-membered cyclized alkenyl group which may have a substituent
- the above-mentioned hydrogenation is carried out during the method A.
- R 10 is a 5-1 • membered cycloalkyl group optionally having a corresponding substituent, to obtain the compound (1A) of the present invention.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the step of the above-mentioned hydrogenated kamitsu can be carried out, if appropriate, by changing the order.
- Method H can be carried out in an inert solvent or in the absence of a solvent, in an atmosphere of an inert gas or in an atmosphere, in the presence or absence of a base, in the presence or absence of an additive, or in the presence or absence of an additive.
- R10, R20, R21, R22, R23, R30, R31, R32, R40, n and W1 and R10a, R20a, R21a , R22a, R23a, R30a, R31a, R32a and R40a are as defined above.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step. Specifically, methanol, ethanol, and n-propanol are used. , Isoprono ,. Nore, n-butano, isobutano
- T-butanol isoamino phenol, diol, glycerin, octanol, alcohol, hexane, alcohol, methyl sorb, benzene, benzene, 1,2-dichlorobenzene, Aromatic hydrocarbons such as tosoleene, xylene, ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycol dimethyl ether, dimethylformamide, dimethylacetamide, hexametinolelate triamido And amides such as N-methylpyrrolidone.
- Aromatic hydrocarbons such as tosoleene, xylene, ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycol dimethyl ether, dimethylformamide
- a microwave reaction apparatus can be used, or the reaction can be performed using an alumina-silica gel as a carrier.
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product. Specifically, triethylamine, pyridine and diisopropyl ester are used. Organic bases such as tilamine, 4-dimethylaminopyridine, DBU and DABCO or inorganic bases such as potassium carbonate, sodium carbonate and sodium hydrogencarbonate can be mentioned.
- the desired compound can be obtained.
- alkali metal iodides such as sodium iodide and potassium iodide can be mentioned.
- the reaction temperature varies depending on the starting material, solvent and reagent, but is usually from 0 to 270 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.5 to 100 hours.
- the compound (1A) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1A) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 is a 5- to 10-membered cycloalkyl group optionally having a substituent
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- R10, R20, R21, R22, R23, R30, R31, R32, R40, n and W1a and R20a, R21a, R22a, R23a , R30a, R31a, R32a and R40a are as defined above.
- R 10b represents a 5- to 10-membered cycloalkenyl group which may have a substituent, and the substituent may be protected. It has the same meaning as the substituent defined for "a good 5- to 10-membered cycloalkyl group".
- Mlb represents two groups of the formula B (OE 10c ) or three groups of the formula Sn (E 10b ) (wherein, E 10c is a C 16 alkyl group or two substituted together with a methyl group Represents an optionally substituted C 2-3 alkylene group, and E 1Db represents a C 1-6 alkyl group. This method differs depending on Mlb .
- This method is carried out in an inert solvent, in the presence of a palladium (0) catalyst, in the presence of a base, in the presence or absence of a carohydrate, in an atmosphere of an inert gas or in a non-atmosphere, and in the presence of a compound (13) And the compound (14) are reacted with each other to remove a protecting group of the resulting compound as required, thereby producing a compound (1A) of the present invention (a compound in which XI in the above formula (1) is a nitrogen atom). Or a method for producing compound (100) of the present invention by subjecting compound (190) to a reaction similar to the above.
- amides such as formamide, dimethylformamide, dimethylacetamide, hexamethylphosphate triamide, N-methylpyrrolidone, tonolene, and benzene
- Aromatic hydrocarbons such as xylene, mesitylene, ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycol ⁇ "dimethyl ether, methanol, ethanol, n- propanoic acid Alcohols such as alcohol, isopropanol, n-butanol, isobutanol, t-butanol, isoamyl alcohol, diethylene glycol, glycerin, octanol, cyclohexanol, and methyl sorb Examples thereof include nitriles such as
- the palladium (0) catalyst used it is possible to obtain the target compound and does not generate inseparable by-products
- the various palladium complexes serving as the palladium (0) precursor are not particularly limited as long as they can obtain the target compound and do not generate inseparable by-products.
- the ligand there is no particular limitation on the ligand as long as it can obtain the target compound and does not produce inseparable by-products.
- Triphenyl olenophosphine tri-t-butyl phosphine, tri- (4-methylphenyl-phosphine) phosphine, 2- (g-t-pentinolephosphine) bipheninole, 2- (dicyclohexyl / lephosphino) bife Binore, tricyclohexynolephosphine, 1,
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product, but specific examples thereof include potassium phosphate and phosphoric acid. Tri sodium, cesium carbonate, carbonated lime, sodium carbonate
- Inorganic bases such as cesium bicarbonate, hydrogen bicarbonate, sodium bicarbonate, sodium acetate, sodium acetate, barium hydroxide, potassium hydroxide, potassium fluoride, cesium fluoride, sodium ethoxide, sodium-t-topoxide, Metal alkoxides such as acetic acid; sodium acetate; alkali metal acetates such as potassium acetate; and organic bases such as triethylamine.
- the additive used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product, but specific examples thereof include lithium chloride and sodium chloride. , Lithium bromide, sodium bromide, tetrabutylammonium bromide and the like.
- the reaction temperature varies depending on the starting material, solvent and reagent, but is usually 0 to 150 ° C, preferably 20 to 120 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.5 to 100 hours, preferably 0.5 to 48 hours.
- an inert gas there is no particular limitation as long as the reaction in this step is not hindered. Specifically, argon or nitrogen gas is used.
- references that complement the above method include Tetrahedron of SP Stanforth. (1998), 54, 263. and Miyaura, A. Suzuki CO Chera. Rev. (1995), 95, 2457, but are not limited thereto. .
- This method comprises the steps of reacting compound (13) with compound (1) in an inert solvent, in the presence of a palladium (0) catalyst, in the presence or absence of additives, in an inert gas atmosphere or in a non-atmosphere. 4) to remove the protecting group of the resulting compound as desired, thereby producing a compound (1A) of the present invention (a compound in which X 1 in the above formula (1) is a nitrogen atom). Or a method for producing compound (100) of the present invention by subjecting compound (190) to the same reaction as described above.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction of this step.
- the palladium (0) catalyst to be used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product. Specifically, tetrakis (trif) Enylphosphine) palladium, tris (dibenzylideneacetone) dipalladium, bis (dibenzylideneacetone) palladium, bi (tri-t-butylphosphine) palladium, palladium black, etc., or the palladium (0) precursor shown below Is a palladium (0) catalyst generated in a reaction system by a combination of various palladium complexes and various ligands shown below.
- the various palladium complexes serving as the palladium (0) precursor are not particularly limited as long as the desired compound can be obtained and do not generate inseparable by-products.
- the ligand is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product.
- Triphenylphosphine tri-t-butylphosphine, tri (4-methinolephenyl) phosphine, 2— ( -T-butylphosphino) biphenyl, 2- (dicyclohexylphosphino) biphenyl, tricyclohexynolephosphine, tree 2-furinolephosphine, 1,1, -bis (diphenylinolephosphino) Sen, G-butynolephosphonidum trafluoropolate, triphenylenylarsine and the like.
- the additive sigma used is not particularly limited as long as the target compound can be obtained and does not generate inseparable by-products.
- cesium fluoride examples thereof include potassium fusidani, lithium chloride, lithium bromide, sodium bromide, tetrabutyl fluoride / leammonium fluoride, copper iodide, copper oxide, and zinc chloride.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 0 to 150 ° C, preferably from 20 to 110 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.1 to 100 hours, preferably 0.5 to 48 hours.
- references supplementing the above method include Tetrahedron of S. P. Stanforth.
- the compound (1A) of the present invention and the compound (.100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1A) and the obtained compound (100) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the method described above in Method A is used.
- R 10 of the obtained compound (100) may have a substituent.
- compound (1B) of the present invention (compound of formula (1) in which XI is a CH group) can be obtained by hydrogenation.
- the obtained compound is desired to be converted to an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step may be carried out in a different order if appropriate.
- the M method uses an inert gas atmosphere in the presence of a palladium (0) catalyst in inert mixed Ij.
- Compound (16) with boron metal reagent (15) or tin metal reagent (15) under or without atmosphere, in the presence or absence of base, in the presence or absence of additives By reacting (Suzuki reaction or Stille reaction), the protecting group of the resulting compound is optionally removed, whereby the compound (1A) of the present invention (compound where XI in the above formula (1) is a nitrogen atom) is obtained.
- This is a method for producing the compound (100) of the present invention by subjecting the compound (180) to the same reaction as described above.
- R10, R20, R21, R22, R23, R30, R31, R32, R40, n and W1a and R20a, R21a, R22a, R23 a, R30a, R31a, R32a and R40a are as defined above.
- R 10 b is as defined above.
- Ml formula: B (OE 10 a) 2 group, or the formula S n (E 10b) shows a 3 group (wherein, E 1QA is hydrogen atom, C 1 one 6 alkyl group or two together such connection, A C 2-3 alkylene group which may be substituted with a methyl group, and E 1 () b represents a C 1-6 alkyl group).
- This method can be performed according to the above-mentioned K method.
- the compound (1A) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1A) and the obtained compound (100) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the method A By the above-mentioned hydrogenation, the compound (1A) of the present invention or the compound of the present invention, wherein R 10 is a 5- to 10-membered cycloanolealkyl group optionally having a corresponding substituent.
- 1 B) (Compound (1) wherein X 1 is a compound of the formula CH group) can be obtained. Further, R 10 of compound (100) obtained may have a substituent.
- the compound of the present invention is obtained by hydrogenation. 4019795
- (IB) (a compound in which X 1 in compound (1) has the formula CH group) can be obtained. Further, when the obtained compound is desired to be converted to an acid salt, it can be carried out according to a conventional method. In addition, the step of producing the salt and the above-described hydrogenation step may be carried out in a different order if appropriate.
- a compound (17) is reacted with a halogenating reagent in an inert solvent in the presence or absence of a carohydrate, in the presence or absence of an inert gas, and R 10a is bonded.
- This is a method for producing the compound (1) of the present invention by obtaining a compound having a halogenated benzene ring (N-111 step) and optionally removing the protecting group of the obtained compound.
- R32a and R4Oa are as defined above.
- at least one of R 20b, R 2 lb, R 22b and R 23b is a hydrogen atom, and the rest represent groups corresponding to R 20a, R21a, R22a and R23a, respectively. .
- the solvent to be used is not particularly limited as long as it does not dissolve the starting compound to some extent and inhibits the reaction in this step. Specifically, methanol, ethanol, n-propanol, Isoproponolol, n-butanol, isobutanol, t-butanol, isoaminoethanol, diethylene glycolone, glycerin, liquoranophenol, cyclohexanol ', methylcellonolace
- Aliphatic hydrocarbons such as hexane, heptane, rig-mouth, petroleum ether, ethers, such as dioxane, dimethoxetane, diethyleneglyconoresimetinoleatenole, chlorophonolem, dichloromethane, 1,2-dichloroethane, Halogenated hydrocarbons such as carbon chloride, ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycol dimethyl ether, formamide, dimethylformamide, dimethylacetate Amides, amides such as hexamethylphosphoric triamide, and organic acids such as acetic acid can be mentioned, and preferred are alcohols (particularly methanol).
- the halogenating reagent to be used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product ′.
- Examples of the additive used include acetates of alkali metals such as sodium acetate and potassium acetate, and preferably, sodium acetate.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 120 to 100 ° C, preferably from 20 to 50 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually from 0.25 to 48 hours, preferably from 12 to 24 hours.
- the compound (1) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the halogen introduced by introducing the hydrogenation described above is used.
- the compound of the present invention, wherein R 10 is a 5- to 10-negative cycloalkyl group, wherein R 10 may have a corresponding substituent, by changing and carrying out reaction conditions in which atoms remain unreduced. Can be obtained.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- the halogen compound obtained in the N-1-1 process is converted into a compound having a desired substituent in the presence of a transition metal catalyst, and the protecting group of the obtained compound is optionally removed by a method described later. This is a step for producing the compound (1) of the present invention.
- the aryl halide compound obtained in the N-111 step is capable of forming a desired substituent in the presence of a transition metal such as palladium, copper, nickel, zinc, or zirconium, or a catalyst comprising a combination of such a metal and a ligand. Or a compound capable of introducing Various cross-coupling reactions can be performed with the reactive derivative.
- the bond formation reaction modes are carbon atom-carbon atom bond formation reaction and carbon atom-nitrogen atom bond formation reaction.
- reaction when morpholine is to be introduced as a substituent in a carbon-nitrogen atom bond formation reaction, the reaction can be performed as follows.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- aromatic hydrocarbons such as benzene, toluene, and xylene
- ethers such as dioxane, dimethoxetane and tetrahydrofuran, and amides such as dimethylformamide, and preferably xylene.
- the additive used is not particularly limited as long as it can obtain the target compound and does not generate an inseparable by-product, but a palladium catalyst such as palladium acetate (II) And potassium t-butoxide and sodium t-butoxide, bases such as cesium carbonate, and 2,2,1-bis (diphenylphosphino) 1-1,1′-binaphthy / re, tri-t-butylphosphonium tetrafluoate Phosphines such as roborate can be appropriately selected. It is a harmony of palladium (II) acetate, sodium t-butoxide and tri-t-buty-phosphoniumtetrafluoroborate.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually 50 to 200 ° C, preferably 70 to 150 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.5 to 72 hours, preferably 2 to 24 hours.
- the compound (1) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 can be obtained by hydrogenation described above during Method A.
- Compound (1) of the present invention in which 10 is a 5- to 10-membered cycloalkyl group optionally having a corresponding substituent can be obtained.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- the compound (18) is reacted with a trifluoromethanesulfonylating agent in an inert solvent to obtain a compound in which the phenolic hydroxyl group is trifluorosulfonated with methanesulfonylation (P-11 step 1).
- the method for producing the compound (1) of the present invention by removing the protecting group of the compound to be obtained as required, or the method for preparing the phenyl triflate compound according to (? _1-1) above Reacts with a compound capable of introducing a substituent of formula (1) or a reactive derivative thereof (P-1-2 step),
- This is a method for producing the compound (1) of the present invention by removing the compound as desired.
- This method can be carried out when a phenolic hydroxyl group is present on the benzene ring to which R10a is bonded.
- R31, R32, R40, n and X1 and R10a, R30a, R31a, R32a and R40a are as defined above.
- one of R 20 c, R 2 lc, R 22 c and R 23 c is a phenolic hydroxyl group, and the rest correspond to R 20 a, R 21 a, R 22 a and R 23 a, respectively. ⁇ indicating the base
- This step can be performed according to the sulfonylation method described in the above-mentioned method (1) or (2).
- Compound (1) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- Compound (1) of the present invention wherein R 10 is a 5- to 10-membered cycloalkyl group optionally having a substituent, can be obtained.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a standard method.
- the step of producing the salt and the above-mentioned step of hydrogenation can be carried out by changing the order, if appropriate.
- P-1-1 The trifluoromethanesulfonyloxy group of the compound obtained in one step This is a step of converting into a desired substituent.
- This step can be performed according to the above-mentioned N-1-2 method.
- References that further complement this method include, but are not limited to, Kurt Ritter; Synthesis, (1993), 735.
- the compound (1) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 can be obtained by hydrogenation described above during Method A.
- Compound (1) of the present invention wherein 10 is a 5-1 O-membered cycloalkyl group optionally having a corresponding substituent can be obtained.
- the reaction can be performed according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- a compound (19) is reacted with compound (20) in an inert solvent, in the presence of a reducing agent, in the presence or absence of an acid, and in the presence of an additive, and the protecting group of the compound obtained is obtained.
- This is a method for producing a compound (1A) of the present invention (a compound in which X 1 in the above formula (1) is a nitrogen atom) by removing the compound as required.
- R 10, R 20, R 2 1, R 22, R 23, R 30, R31, R 32, R40, n and W 1 and R 10 a, R 20 a s R 2 1 a R22a, R23a and R40a are as defined above. Also, E 1
- This method can be performed according to the above-mentioned method C.
- the compound (1A) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1A) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 is a 5- to 10-membered cycloalkyl group optionally having a substituent
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- the compound (21) is reacted with a base in an inert solvent to remove the protecting group of the resulting compound, if desired.
- R 10, R20, R 21 , R 22, R23, R 30, R 3 1, R 32, R40, n and Wl and R 1 0 a, R 20 a s R 2 1 a, R 22 a R23a and R40a are as defined above.
- E4, E5 and E6 are the desired equations
- This method can be performed according to the above-mentioned Method A.
- the compound (1A) of the present invention can be isolated or purified from the reaction mixture obtained as described above by the method described below.
- R 10 of the obtained compound (1A) is a 5- to 10-membered cyclized alkenyl group which may have a substituent
- the above-mentioned hydrogenation is carried out during the method A.
- R 10 is a 5- to 10-membered cycloalkyl group optionally having a corresponding substituent, to obtain the compound (1A) of the present invention.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- the method S is carried out by reacting the compound (22) with the compound (9) in an inert solvent with a palladium (0) catalyst, followed by hydrogenation to remove the protecting group of the resulting compound as desired.
- a method for producing the compound (IB) of the invention (compound wherein X 1 in the above formula (1) is a formula CH group) (Method S-1), or alternatively, compound (22) and compound ( 9) to remove the protecting group of the resulting compound if desired.
- To produce the compound (100) of the present invention (Method S-2), and if necessary, hydrogenation to lead to the compound (1B) of the present invention (Method S-3) ).
- R10, R20, R21, R22, R23, R30, R31, R32, R40, n, Wla and Mlb and R10a, R20a, R21a, R 22a, R23a, R30a, R3la, R32a and R40a are as defined above.
- This method can be performed according to the above-mentioned hydrogenation reaction during the above-mentioned method K and then the method A.
- the compound (1B) of the present invention and the compound (10 O) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- the obtained compound is to be converted into an acid salt, it can be carried out according to a standard method.
- the step of producing the salt and the step of hydrogenating the compound (22) after reacting the compound (22) with the compound (9) can be carried out in a different order, if appropriate.
- compound (24) is reacted with compound (25) in an inert solvent in the presence of a palladium (0) catalyst, followed by hydrogenation to remove a protecting group of the obtained compound as desired.
- This is a method for producing the compound (1) of the present invention (compound in which XI in the above formula (1) is a CH group) (method 1-1) or a compound similar to the above method. Reaction of (24) with compound (25), protection of the resulting compound The compound (100) of the present invention is produced by removing the group as required (method T-2), and if necessary, hydrogenation is carried out to obtain the compound (1B) of the present invention (T13). Law).
- R10, R20, R21, R22, R23, R30, R31, R32, R40, n, Wla and M1 and R10b, R20a, R21 a, R22a, R23a, R30a, R31a, R32a and R40a are as defined above.
- This method can be carried out according to the above-mentioned hydrogenation reaction during the above-mentioned method K and then method A.
- the compound (1B) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained above by the method described later.
- the obtained compound When the obtained compound is to be converted into an acid salt, it can be carried out according to a standard method.
- the step of producing a salt and the step of hydrogenating the compound (24) after the compound (24) is reversed may be carried out in a different order, if appropriate.
- Method U is based on compound (26) and compound (27) (in other words, lithium Reacting with the reagent or Grignard reagent) to obtain the adduct (170) (step 17_1-1), and then reducing the benzylic hydroxyl group of the obtained adduct compound (170) by (U-1— 2)) and further removing the protecting group as desired to obtain a compound (1B) of the present invention (a compound in which X 1 in the above formula (1) is a formula CH group).
- the adduct (170) is obtained by reacting in the same manner as in the above method (U-1-1), and the hydroxyl group of the compound (170) is dehydrated in the presence or absence of an acid. (U-11 step) and a method for producing the compound (100) of the present invention by further removing a protecting group as required.
- M2 is a lithium or magnesium halide.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, Ethers such as dimethoxetane and diethylene glycol dimethyl ether can be mentioned, and preferred is tetrahydrofuran.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually ⁇ 80 to 30 ° C.
- reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.25 to 6 hours.
- This step can be carried out by a reduction method carried out according to the hydrogenation method described in the above-mentioned Method A, or by a reduction method using trianolequinolesylinohydride described below.
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- the solvent used in the reduction reaction with trianolequinolesilyl hydride is specifically mentioned.
- haptic hydrocarbons particularly dichloromethane
- octaform dichloromethane
- dichloromethane 1,2-dichloroethane and carbon tetrachloride.
- the reducing agent to be used is not particularly limited as long as it can obtain a target compound and does not produce an inseparable by-product, and specific examples thereof include triethylsilyl hydride and triethylsilyl hydride.
- Triethylsilyl hydrides such as isopropylsilyl hydride can be mentioned, and preferred is triethynolesilyl hydride.
- the additive to be used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product, but specific examples thereof include triflouroacetic acid.
- Examples include Lewis acids such as halo-substituted acetic acids and boron trifluoride.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 70 to 50 ° C.
- reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually 0.5 to 48 hours.
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- Preferred are tetrahydrofuran and toluene. Methane, dichloromethane, chlorophonolem, and water.
- the acid additive to be used is not particularly limited as long as it can obtain a target compound and does not produce an inseparable by-product.
- trifluoroacetic acid is used. Examples thereof include halo-substituted acetic acids, Lewis acids such as boron trifluoride, organic sulfonic acids such as toluenesulfonic acid and camphorsulfonic acid, and inorganic acids such as hydrochloric acid and hydrobromic acid.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 80 to 180 ° C.
- reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually from 0.25 to 24 hours.
- the compound (1B) of the present invention and the compound (100) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1B) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the compound (1 B) of the present invention, in which R 10 is a 5-membered cycloalkyl group which may have a corresponding substituent can be obtained.
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method.
- the step of producing the salt and the above-described hydrogenation step can be carried out in a different order if appropriate.
- the compound (53) is reacted with the compound (150) (that is, a lithium reagent or a Grignard reagent) in an inert solvent to obtain an adduct (140) (V-11) Step), and then reducing or dehydrating, if necessary, the benzylic hydroxyl group of the resulting adduct compound (140) (step V-1-2), and, if necessary, removing the protecting group if necessary.
- the compound (150) that is, a lithium reagent or a Grignard reagent
- R10, R20, R21, R22, R23, R30, R31, R32, R40, X1 and n and R10a, R20a, R21a, R22 a, R 23a, R 30a, R 31a and R 32a are as defined above.
- M2 is a lithium or magnesium halide.
- R 200 has the same meaning as the substituents contained in the aforementioned substituent group A1, or is a group in which the substituent on these substituents is protected.
- u is an integer of 0, 1, 2, 3, 4 or 5.
- k is an integer of 0, 1, 2, 3, 4 or 5.
- PR40a has the same meaning as R40a described above, or is an amino-protecting group (preferably a t-butoxycarbonyl group or a benzyl group).
- This method can be carried out according to the hydrogenation reaction described in the above-mentioned Method U and subsequently in Method A.
- the compound (1) and the compound (2) of the present invention can be isolated or purified from the reaction mixture obtained as described above by a method described later.
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- R 10 of the obtained compound (1) is a 5- to 10-membered cycloalkenyl group which may have a substituent
- the obtained compound when it is to be converted into an acid salt, it can be carried out according to a conventional method. It should be noted that the step of producing the salt and the step of hydrogenation described above, if appropriate, The order can be changed.
- the protecting group for the amino group is an optionally substituted silyl group such as, for example, trimethylsilyl, triethylsilyl, triisopropylsilyl, t-butyldimethylsilyl, or t-butyldiphenylsilyl
- the fluorinated group is usually fluorinated. It is removed by treatment with compounds that produce fluorine anions, such as tetrabutylammonium, hydrofluoric acid, hydropyridine monopyridine, and potassium fluoride.
- the inert solvent used in the above reaction is not particularly limited as long as it does not inhibit the reaction, and examples thereof include getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycolone resin methinolate ether. Such ethers are preferred.
- reaction temperature and reaction time are not particularly limited, but usually the reaction temperature is 0 ° C. to 50 ° C., and the reaction time is 10 hours to 18 hours.
- the protecting group of the amino group is an optionally substituted aliphatic acyl group, an optionally substituted aromatic acyl group, an optionally substituted alkoxycarbonyl group or a substituted methylene group which forms a Schiff base. Can be removed by treating with an acid or a base in the presence of an aqueous solvent.
- the acid used in the above reaction is not particularly limited as long as it is an acid generally used for removing the protecting group for the amino group.
- the acid include hydrobromic acid, hydrochloric acid, sulfuric acid, perchloric acid, An inorganic acid such as phosphoric acid or nitric acid, or an organic acid such as trifluoroacetic acid or trifluoromethanesulfonic acid, preferably hydrochloric acid or trifluoroacetic acid.
- the base used in the above reaction is not particularly limited as long as it is a base usually used for removing the protecting group for the amino group.
- lithium carbonate, sodium carbonate, and potassium carbonate are used.
- Alkali metal carbonates such as lithium hydroxide, sodium hydroxide and potassium hydroxide; lithium metal oxides such as lithium methoxide, sodium methoxide, sodium methoxide, potassium methoxide Metal alkoxides; or ammonia such as aqueous ammonia or concentrated ammonia-methanol.
- Solvents used in the above reaction include, for example, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, isoaminophenol, diethylene glycol, Alcohols such as glycerin, octananol, silk hexanol, and methylcelloso / lev; ethers such as ethynoleate, diisopropyl ether, tetrahydrofuran, dioxane, dimethyloxetane, diethylene glycol dimethinoleether; water; It is a mixed solvent with a solvent, and is preferably an alcohol (most preferably, ethanol).
- reaction temperature and reaction time vary depending on the starting compound, the solvent and the acid or base used, and are not particularly limited.However, in order to suppress a side reaction, the reaction temperature is usually from 0 ° C to 150 ° C And the reaction time is 1 hour to 10 hours.
- the protecting group for an amino group is an optionally substituted aralkyl group or an optionally substituted aralkyloxycarbonyl group
- the protecting group is usually brought into contact with a reducing agent in an inert solvent (preferably, For this purpose, a method of removing by catalytic reduction at room temperature under a catalyst or a method of removing using an oxidizing agent is preferable.
- the inert solvent used for the removal by catalytic reduction is not particularly limited as long as it is inert to the present reaction.
- aliphatic hydrocarbons such as hexane, heptane, lignin, and petroleum ether
- Aromatic hydrocarbons such as toluene, benzene and xylene; methyl acetate, ethyl acetate, propyl acetate, butyl acetate and getyl carbonate Esters such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethyleneglyconoresimetinoleatel; methanol, ethanol, n-propanol, isoprono.
- Alcohols such as ethanol, acetic acid, organic solvents such as acetic acid, such as phenol, phenol, phenol, glycerol, glycerol, cyclohexanol, methyl-butanol, n-butanol, isobutanol, isobutanol, t-butanol, diisoamyl alcohol, diethylene glycolone Acid; water; or a mixed solvent of the above solvent and water, preferably alcohols, ethers, organic acids or water (most preferably, alcohols or organic acids).
- acetic acid such as phenol, phenol, phenol, glycerol, glycerol, cyclohexanol, methyl-butanol, n-butanol, isobutanol, isobutanol, t-butanol, diisoamyl alcohol, diethylene glycolone Acid
- water or a mixed solvent of the above solvent and water, preferably alcohols
- the catalyst used for removal by catalytic reduction is preferably palladium monocarbon, Raney-nickel, platinum oxide, platinum black, rhodium aluminum monoxide, trifininole phosphine rhodium monochloride, or palladium monosulfate.
- the pressure is not particularly limited, but is usually 1 to 10 atm.
- reaction temperature and the reaction time vary depending on the starting compound, the catalyst, the inert solvent, etc., but usually the reaction temperature is from 0 ° C to 100 ° C, and the reaction time is from 5 minutes to 72 hours. .
- the inert solvent used in the removal by oxidation is not particularly limited as long as it does not participate in the present reaction, but is preferably a water-containing organic solvent.
- organic solvents include, for example, halogenated hydrocarbons such as chloroform, dichloromethane, 1,2-dichloroethane, and tetrachlorosilane; nitriles such as acetonitrile; dimethyl ether; diisopropyl ether; and tetrahydrofuran.
- Amides such as dioxane, dimethoxetane, diethyleneglycol / resinmethinol ether; ketones such as acetone; amides such as formamide, dimethylformamide, dimethylacetamide, and hexamethylphosphoric triamide.
- sulfoxides such as dimethyl sulfoxide and sulfolane, preferably halogenated hydrocarbons, ethers or sulfoxides (most preferably halogenated hydrocarbons or sulfoxides).
- the oxidizing agent used in the above reaction is not particularly limited as long as it is an oxidizing agent used for removing the protecting group for the amino group, but is preferably potassium persulfate, sodium persulfate, ammonium sulfate, or the like. It is umnailitate (CAN) or 2,3-dichloro-5,6-dicyanor p-benzoquinone (D.DQ).
- reaction temperature and reaction time vary depending on the starting compound, oxidizing agent, solvent, etc., but usually
- the reaction temperature is 0 ° C. to 150 ° C., and the reaction time is 10 minutes to 24 hours.
- the protecting group of the amino group is an aralkyl group which may be substituted
- the protecting group can be removed using an acid or a base.
- the acid used in the above reaction is not particularly limited as long as it is an acid used for removing the aralkyl group which may be substituted, which is a protecting group for the amino group.
- the acid include hydrochloric acid and bromide.
- Inorganic acids such as hydrogen acid, sulfuric acid, perchloric acid, phosphoric acid; acetic acid, formic acid, oxalic acid, methanosulfonic acid,-like toluenesulfonic acid, camphorsulfonic acid, triflic acid, trifluoromethanesulfonic acid Blenstead acids, such as organic acids; Lewis acids, such as zinc chloride, tin tetrachloride, boron trichloride, boron trifluoride, and boronantripromide; or acidic ion exchange resins, preferably inorganic acids or organic acids ( Most preferably, hydrochloric acid, acetic acid or trifluoroacetic acid).
- the base used for the above reaction is not particularly limited as long as it is a base used for removing a substituted or unsubstituted aralkyl group which is a protecting group for the amino group.
- Alkali metal carbonates such as lithium, sodium carbonate, and potassium carbonate;
- Al metal hydroxides such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; lithium methoxide, sodium methoxide, sodium methoxide, and potassium hydroxide metal alkoxides such as t-butoxide; or ammonia such as ammonia water and concentrated ammonia-methanol.
- the inert solvent used in the first-stage reaction is not particularly limited as long as it is inert to the present reaction.
- hexane, heptane, lignin, petroleum ether Aliphatic hydrocarbons such as benzene, toluene, xylene; halogenated hydrocarbons such as chloroform, dichloromethane, 1,2-dichloroethane and carbon tetrachloride; methyl acetate; Esters such as ethyl acetate, propyl acetate, butyl acetate, and getyl carbonate; ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycol dimethyl ether; methanol, ethanol, n-propanol, and isopropanol , N-butanol, isobutanol, t-butanol,
- the reaction temperature varies depending on the starting compound, the acid used, the solvent, and the like, but is usually from ⁇ 20 ° C. to the boiling point (preferably from 0 ° C. to 100 ° C.).
- the reaction time varies depending on the starting compound, the acid used, the inert solvent, the reaction temperature and the like, but is usually 15 minutes to 48 hours (preferably 30 minutes to 2 hours).
- the protecting group of the above is an alkenyloxycarbonyl group which may be substituted
- the protecting group of the amino group is usually the above-mentioned aliphatic acyl group which may be substituted, optionally substituted, aromatic acyl group.
- the group is removed by treating with an acid or a base in the same manner as in the removal reaction when the group is a substituted or substituted methylene group which forms a Schiff base.
- the method of removing with palladium and triphenylphosphine or nickel tetracarbonyl is simple and can be carried out with few side reactions.
- the protecting group for the amino group is an alkyl group which may be substituted, an alkenyl group which may be substituted or a sulfonyl group which may be substituted
- the protecting group for the amino group is usually the above-mentioned aliphatic acryl group, It is carried out by treating with an acid or a base in the same manner as in the removal reaction for an aromatic acyl group, an optionally substituted alkoxycarbonyl group or a substituted methylene group forming a Schiff base.
- the protecting group for the hydroxyl group is an optionally substituted silyl group such as, for example, trimethylsilyl, triethylsilyl, triisopropylsilyl, t-butyldimethylsilinole, or t-butyldiphenylsilyl
- tetrabutylammonium fluoride is usually used.
- hydrofluoric acid such as hydrofluoric acid, hydrofluoric acid-pyridine or hydrofluoric acid, or hydrochloric acid, hydrobromic acid, sulfuric acid or perchloric acid, phosphoric acid It can be removed by treating with an inorganic acid or an organic acid such as acetic acid, formic acid, oxalic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoroacetic acid or trifluoromethanesulfonic acid.
- an inorganic acid or an organic acid such as acetic acid, formic acid, oxalic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoroacetic acid or trifluoromethanesulfonic acid.
- reaction when removing with a fluorine anion, the reaction may be accelerated by adding an organic acid such as formic acid, acetic acid or propionic acid.
- organic acid such as formic acid, acetic acid or propionic acid.
- the inert solvent used in the above reaction is not particularly limited as long as it is inert to the present reaction, but is preferably dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethyloxetane, or diethylene glycolone. Diethynole, ethenoles such as ethereol; acetonitrile, nitriles such as isobutyronitrile; organic acids such as acetic acid; water; or a mixed solvent of the above solvents.
- reaction temperature and reaction time vary depending on the starting compound, catalyst, inert solvent, etc., but usually, the reaction temperature is 0 ° C to 100 ° C (preferably 10 ° C to 50 ° C). And the reaction time is 1 hour to 24 hours.
- the protecting group for the hydroxyl group is an optionally substituted aralkyl group or an optionally substituted aralkyloxycarbonyl group
- it is usually contacted with a reducing agent in an inert solvent (preferably , Catalytic reduction at room temperature in the presence of a catalyst)
- a reducing agent inert solvent (preferably , Catalytic reduction at room temperature in the presence of a catalyst)
- an inert solvent preferably , Catalytic reduction at room temperature in the presence of a catalyst
- the inert solvent used for the removal by catalytic reduction is not particularly limited as long as it does not participate in the reaction.
- aliphatic hydrocarbons such as hexane, heptane, rigoin, and petroleum ether
- Aromatic hydrocarbons such as toluene, benzene and xylene
- Esters such as ethyl acetate and propyl acetate
- the catalyst used for removal by catalytic reduction is not particularly limited as long as it is used for removing the protecting group for a hydroxyl group by catalytic reduction.
- Examples thereof include palladium carbon, palladium black, and Raney nickel.
- the pressure is not particularly limited, but is usually 1 to 10 atm.
- reaction temperature and reaction time vary depending on the starting compound, catalyst, inert solvent, etc., but usually, the reaction temperature is 0 ° C to 100 ° C (preferably 20 ° C to 70 ° C). And the reaction time is 5 minutes to 48 hours (preferably 1 hour to 24 hours).
- the inert solvent used in the removal by oxidation is not particularly limited as long as it does not participate in the reaction, but is preferably a water-containing organic solvent, for example, ketones such as acetone; methylene chloride Haloke 'like chloroform, carbon tetrachloride Hydrocarbons; nitriles such as acetonitrile; ethers such as getyl ether, tetrahydrofuran, dioxane; amides such as methylformamide, dimethylase1, amide, and hexamethylphosphate triamide Or sulfoxides such as dimethyl sulfoxide.
- ketones such as acetone
- methylene chloride Haloke 'like chloroform carbon tetrachloride Hydrocarbons
- nitriles such as acetonitrile
- ethers such as getyl ether, tetrahydrofuran, dioxane
- amides such as methylformamide, di
- the oxidizing agent used in the above reaction is not particularly limited as long as it is an oxidizing agent used for removing the protecting group for the hydroxyl group, but is preferably potassium persulfate, sodium persulfate, or ammonia.
- Islamum nate (CAN) or 2,3-dichloro-5,6-dicyanor p-benzoquinone (DDQ) is used.
- reaction temperature and reaction time vary depending on the starting compound, oxidizing agent, inert solvent, etc., but usually the reaction temperature is 0 ° C to 150 ° C, and the reaction time is 10 minutes to 24 hours. It is.
- alkali metals such as lithium metal and sodium metal
- alkylsilyl halide such as sodium aluminum chloride iodide or trimethylsilyl iodide in an inert solvent.
- the inert solvent used in the above reaction is not particularly limited as long as it does not participate in this reaction, but is preferably a halogenated hydrocarbon such as methylene chloride, chloroform, and carbon tetrachloride. Nitrinoles such as acetonitrile; or a mixed solvent of the above solvents. '
- reaction temperature and the reaction time vary depending on the starting compound, the inert solvent and the like, but usually the reaction temperature is from 0 ° C to 50 ° C, and the reaction time is from 5 minutes to 72 hours.
- the protecting group for a hydroxyl group is an aliphatic acyl group, an aromatic acyl group or an optionally substituted alkoxycarbonyl group, it is removed by treatment with a base in an inert solvent.
- the base used in the above reaction is not particularly limited as long as it is a base used for removing the protecting group for the hydroxyl group.
- the base include alkali metal carbonates such as lithium carbonate, sodium carbonate and potassium carbonate.
- Alkali metal bicarbonates such as lithium hydrogen carbonate, sodium hydrogen carbonate and potassium hydrogen carbonate; alkali metal hydroxides such as lithium hydroxide, sodium hydroxide and potassium hydroxide; lithium methoxide, sodium methoxide Metal alkoxides, such as toxide, sodium ethoxide, potassium hydroxide; or ammonia, such as aqueous ammonia and concentrated ammonia and methanol.
- Coxides or ammonia most preferably alkali metal hydroxides or metals Alkoxides).
- the inert solvent used in the above reaction is not particularly limited as long as it is one used in a usual hydrolysis reaction.
- Ethers such as tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycolone dimethinoleate; methanol, ethanol, ethanol, n-pro / cno, isopro / ⁇ 0 , n-butanol
- alcohols such as isobutanol, t-ptanol, isoamyl alcohol, diethylene glycol, glycerin, octanol, cyclohexanol, and methyl sorb, water; and mixed solvents of the above solvents.
- reaction temperature and reaction time vary depending on the starting compound, the base used, the inert solvent, and the like, but the reaction temperature is usually from 120 ° C to 150 ° C to suppress side reactions.
- the reaction time is from 1 hour to 10 hours.
- alkoxymethyl group which may be substituted an alkylthiomethyl group which may be substituted, a tetrahydrovinylyl group, a tetrahydrothiopyranyl group
- ethyl group such as a tetrahydrofuranyl group, a tetrahydrothiofural group or a 1-ethoxyethyl group
- the acid used in the above reaction is not particularly limited as long as it is an acid used for removing the protecting group of the hydroxyl group, and examples thereof include those usually used as Prensted acid or Lewis acid.
- Hydrogen chloride; inorganic acids such as hydrochloric acid, sulfuric acid and nitric acid; or brenstead acids such as organic acids such as acetic acid, trifluoroacetic acid, methanesulfonic acid and p-toluenesulfonic acid: boron trifluoride.
- a Lewis acid, and a strongly acidic cation exchange resin such as Dowex 5 OW can also be used.
- the inert solvent used in the above reaction is not particularly limited as long as it is inert to the present reaction.
- examples thereof include aliphatic hydrocarbons such as hexane, heptane, lignin, and petroleum ether; Aromatic hydrocarbons such as benzene, toluene, and xylene; halogenated hydrocarbons such as methylene chloride, chlorophonolem, carbon tetrachloride, dichloroethane, dichlorobenzene, and dichlorobenzene; ethyl ethyl formate, ethyl ethyl acetate Esters such as acetyl acetate, propyl acetate, butyl acetate, and getyl carbonate; ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, diethylene glycolone resin methino
- reaction temperature and reaction time vary depending on the starting compound, acid used, inert solvent, etc.
- the reaction temperature is from 110 ° C. to 200 ° C. (preferably from 0 ° C. to 150 ° C.), and the reaction time is from 5 minutes to 48 hours (preferably 30 minutes to 10 hours).
- the protecting group for the hydroxyl group is an alkenyloxycarbonyl group which may be substituted or a sulfonyl group which may be substituted
- the protecting group for the hydroxyl group is usually substituted as described above, Group, may be substituted! This can be achieved by treating with a base in the same manner as in the removal reaction in the case of /, an aromatic acyl group or an optionally substituted alkoxycarbonyl group.
- aryloxycarbonyl group use is preferably made of palladium, triphenylphosphine, or bis (methinolespheninolephosphine) (1,5-cyclooctadiene) iridium (I) hexafluorophosphate.
- the method of removal is simple and can be carried out with few side reactions.
- the protecting group of the carboxyl group is a lower alkyl group, a lower alkenyl group or a lower alkyl group, a silyl group which may be substituted, or when the carboxyl group is converted to an orthoester for protection, Alternatively, remove by treating with a base.
- the method or the method of removing with an enzyme is preferred.
- the acid used for the above reaction is not particularly limited as long as it is an acid used for removing the protecting group for the carboxyl group, and is, for example, hydrochloric acid, sulfuric acid, phosphoric acid or hydrobromic acid.
- the base used in the above reaction is not particularly limited as long as it is a base used for removing the protecting group for the carboxyl group.
- alkali metal such as sodium carbonate and carbon dioxide Carbonates
- alkali metal hydroxides such as sodium hydroxide and potassium hydroxide
- concentrated ammonia in methanol preferably sodium hydroxide.
- isomerization may occur in hydrolysis with a base.
- the enzyme used in the above reaction is used to remove the carboxyl protecting group.
- the enzyme is used, for example, various lipases or various esterases. .
- Solvents used in the above reaction include, for example, water or anololecols such as methanol, ethanol and n-propanol; ethers such as tetrahydrofuran and dioxane; or a mixture of the above organic solvent and water Solvent, preferably alcohols
- the reaction temperature and reaction time vary depending on the starting compound, the solvent, the reagent used, and the like, and are not particularly limited.To suppress a side reaction, the reaction temperature is usually 0 ° C. to 220 ° C. The reaction time is from 30 minutes to 10 hours.
- the protecting group for the carboxyl group is an optionally substituted aralkyl group or halogeno lower alkyl group, it is usually removed by reduction in a solvent.
- the reduction method when the protecting group of the carboxyl group is a halogeno lower alkyl group, a method by chemical reduction such as zinc monoacetic acid is preferable, and when the protecting group is a aralkyl group even if it is substituted, It is carried out by a catalytic reduction method using a catalyst such as palladium-carbon, platinum, or a chemical reduction method using an alkali metal sulfide such as potassium sulfide or sodium sulfide.
- a catalytic reduction method using a catalyst such as palladium-carbon, platinum, or a chemical reduction method using an alkali metal sulfide such as potassium sulfide or sodium sulfide.
- the solvent to be used is not particularly limited as long as it does not participate in the reaction; alcohols such as methanol and ethanol; ethers such as tetrahydrofuran and dioxane; fatty acids such as acetic acid; A mixed solvent of a solvent and water is preferred.
- reaction temperature and the reaction time vary depending on the starting compound, the solvent, the reduction method and the like, but usually the reaction temperature is from 0 ° C. to around room temperature, and the reaction time is from 5 minutes to 12 hours.
- alcohols such as methanol, isopropanol, or diethylene glycol
- cyclic or acyclic rings formed with thiols such as methanethiol, ethanethiol, or propanedithiol
- the acid used in the above reaction is not particularly limited as long as it is an acid used for reconverting a cyclic or acyclic ketal converted for the purpose of protecting the carbonyl group into a carbonyl group.
- Inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, perchloric acid, phosphoric acid; acetic acid, formic acid, oxalic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoroacetic acid, trifluoromethane
- a Lewis acid such as zinc chloride, tin tetrachloride, boron trichloride, boron trifluoride, boron tribromide; or an acidic ion exchange resin.
- Inorganic or organic acids (most preferably hydrochloric acid or!)-Toluenesulfonic acid).
- the inert solvent used in the first-stage reaction is not particularly limited as long as it is inert to the present reaction.
- examples thereof include aliphatic hydrocarbons such as hexane, heptane, lignin, and petroleum ether. s; benzene, toluene, aromatic hydrocarbons such as xylene; black hole Holm, dichloromethane, 1, 2 - Jikuroroetan, four halogenated hydrocarbons such as carbon tetrachloride; methyl acetate, acetic Echiru, propyl acetate Esters such as butyl and getyl carbonate; ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycol dimethyl ether; methanol, ethanol, n-propanol, isopropanol, and n-ptanol Nore,
- the reaction temperature varies depending on the starting compound, the acid used, the solvent, and the like, but is usually from 120 ° C to the boiling point (preferably from 0 ° C to 100 ° C).
- the reaction time varies depending on the starting compound, the acid used, the inert solvent, the reaction temperature and the like, but is usually 5 minutes to 48 hours (preferably 10 minutes to 24 hours).
- a method of removing it using a substance such as Raney nickel or silver nitrate is particularly convenient.
- diols For protection of diols, for example, when converted to a cyclic ketal formed using formalin or acetone, it can be converted back to diols using an acid.
- the acid used in the above reaction is not particularly limited as long as it is an acid used for reconverting a cyclic or acyclic ketal converted for the purpose of protecting the diol into a diol.
- inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, perchloric acid, and phosphoric acid; acetic acid, formic acid, oxalic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoroacetic acid, trifluoromethanesulfonic acid
- a prested acid such as an organic acid, such as: a Lewis acid, such as zinc chloride, tin tetrachloride, boron trichloride, boron trifluoride, or boron tribromide; or an acidic ion exchange resin, preferably an inorganic acid.
- an organic acid most preferably hydrochloric acid or p -t
- the inert solvent used in the first-stage reaction is not particularly limited as long as it is inert to the present reaction.
- examples thereof include aliphatic hydrocarbons such as hexane, heptane, lignin, and petroleum ether.
- Aromatic hydrocarbons such as benzene, toluene and xylene; Halogenated hydrocarbons such as chloroform, dichloromethane, 1,2-dichloroethane and carbon tetrachloride; Methyl acetate, ethyl acetate, propyl acetate and acetic acid Esters such as butyl and getyl carbonate; ethers such as getyl ether, disopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycol dimethyl ether; methanol, ethanol, n- Propanol, isopropanol, n-butanol, is
- the reaction temperature varies depending on the starting compound, the acid used, the solvent, and the like, but is usually from 120 ° C to the boiling point (preferably from 0 ° C to 100 ° C).
- the reaction time varies depending on the starting compound, the acid used, the inert solvent, the reaction temperature and the like, but is usually 5 minutes to 48 hours (preferably 10 minutes to 24 hours).
- the removal of the amino, hydroxyl, carbonyl and / or hepoxyl group or the protecting group of the dione may be carried out in any order, and the desired removal reaction may be carried out sequentially.
- the target compound in each step can be collected from the reaction mixture according to a standard method.
- the reaction mixture can be returned to room temperature or ice-cooled, if necessary, to neutralize acids, alkalis, oxidizing agents or reducing agents as appropriate, and not mixed with water and ethyl acetate.
- An organic solvent that does not react with the target compound is added, and the layer containing the target compound is separated.
- a solvent that does not mix with the obtained layer and does not react with the target compound is added, the layer containing the target compound is washed, and the layer is separated.
- the target compound can be collected by drying using a drying agent such as anhydrous magnesium sulfate or anhydrous sodium sulfate and distilling off the solvent.
- the target compound can be collected by subjecting it to electrical desalting and freeze-drying. In addition, if the entire reaction mixture is liquid, and if possible, only by distilling off other than the target compound (eg, solvent, reagent, etc.) under normal pressure or reduced pressure, the target compound can be obtained. Can be collected.
- the target compound eg, solvent, reagent, etc.
- the target is first filtered by a filtration method.
- the compound is collected by filtration, the filtered target compound is washed with an appropriate organic or inorganic solvent, and dried, and the mother liquor is treated in the same manner as in the case where the entire reaction mixture is a liquid. can do.
- the force in which only the reagent or the catalyst exists as a solid, or the case where the entire reaction mixture is a liquid, and only the reagent or the catalyst precipitates as a solid in the course of collection and If the compound is dissolved in the solution, first remove the reagent or catalyst by filtration, wash the filtered reagent or catalyst with a suitable organic or inorganic solvent, combine the resulting washing with the mother liquor, The target compound can be collected by treating the resulting mixture in the same manner as when the entire reaction mixture is liquid.
- the reaction mixture can be used as it is in the next step without isolating the target compound.
- a recrystallization method In order to improve the purity of the target compound collected by the above method, a recrystallization method, various types of mouth chromatography, and a distillation method can be appropriately performed.
- the purity of the target compound can usually be improved by a recrystallization method.
- a single solvent or a mixed solvent that does not react with the target compound can be used. Specifically, first, the target compound is dissolved in one or more solvents that do not react with the target compound at room temperature or under heating. Cool the resulting mixture with ice water or leave at room temperature The target compound can be crystallized from the mixture.
- the purity of the target compound can be improved by the method of seed chromatography.
- weakly acidic silica gels such as silica gel 60 (340-40 omesh) manufactured by Merck or BW-300 (300mesh) manufactured by Fuji Silicon Chemical Co., Ltd. can be used.
- the target compound is basic and the adsorption of the above silica gels is too intense, use a propylamine-coated silica gel (200-30 Omesh) manufactured by Fuji Silicon Chemical Co., Ltd. it can.
- a propylamine-coated silica gel 200-30 Omesh
- NAM-200H or NAM-300H manufactured by Nam Research Laboratory can be used.
- the target compound is eluted with one or more solvents that do not react with the target compound, and the solvent is distilled off, whereby a target compound with improved purity can be obtained.
- the purity of the target compound can be improved by a distillation method.
- the target compound can be distilled off by reducing the pressure of the target compound at room temperature or under heating.
- the above is a typical example of the method for producing the compound (1) and the compound (100) according to the present invention.
- the raw material compound in the production of the compound of the present invention ⁇ the various reagents form salts, hydrates or solvates. All of them may vary depending on the starting materials, the solvent used, and the like, and are not particularly limited as long as they do not inhibit the reaction.
- the solvent used also varies depending on the starting materials, reagents, and the like. Needless to say, the solvent is not particularly limited as long as it does not hinder the reaction and dissolves the starting material in a certain degree of birch.
- the compound (1) and the compound (100) according to the present invention When the compound (1) and the compound (100) according to the present invention are obtained as a free form, the compound (1) and the compound (100) may always form a salt or a hydrate thereof which may be formed. Can be converted according to the law.
- Compound (1) according to the present invention and compound (100) according to the present invention Salt of compound (1). Salt of compound (100), or hydrate and compound (100) of compound (1). When obtained as a hydrate, it can be converted into the free form of the compound (1) and the free form of the compound (100) according to a conventional method.
- various isomers for example, geometric isomers, optical isomers based on asymmetric carbon, rotational isomers, stereoisomers
- various isomers obtained from the compound (1) according to the present invention and the compound (100) according to the present invention , Tautomers, etc.
- Method A and Method V are commercially available. They can be easily produced from commercially available methods by methods well known in the art. It can also be produced by the following method.
- the method is carried out in an inert solvent, in the presence of a palladium (0) catalyst or a copper catalyst, in the presence or absence of a base, in the presence or absence of additives, in an atmosphere of an inert gas or in a non-atmosphere.
- the compound (28) is reacted with the above-mentioned compound (9) (Amination or Amidation), and then the protecting group Pro1 is removed to give the compound (2A) (the above-mentioned compound (2) Wherein X 1 is a nitrogen atom.
- Pro 1 is a protecting group for an amino group, for example, a substituted group such as trimethylsilyl, triethylsilyl, or t-butyldiphenylsilyl.
- a substituted group such as trimethylsilyl, triethylsilyl, or t-butyldiphenylsilyl.
- optionally substituted aliphatic groups such as silyl groups, formyl or acetyl, and substituted groups such as benzoyl; aromatic acyl groups, ethoxycarbonyl or t-butoxycarbonyl.
- Optionally substituted alkoxycarbol groups substituted methylene groups forming Schiff bases, optionally substituted aryl quinolene such as benzyl, 4-methoxybenzyl, or 4-nitrobenzyl
- Optionally substituted alkynoleoxycanolebonyl groups such as groups, benzinolexoxycanoleboninole, 4-methoxypentinoleoxycanoleponyl, or 4,12-opentobenzyloxycarponyl
- Alkenyloxycarbonyls such as quinolinoleoxycanoleponinole or aryloxycanolebonyl
- methoxycarbonyl ethoxycarbonyl, t-butoxycarbonyl and the like.
- a lower alkoxy group substituted by a halogen or a tri-lower alkylsilyl group such as a lower alkoxy canoleponinole group such as isobutoxycarbonyl, a 2,2,2-trichloromouth ethoxycarbonyl, or 2-trimethylsilylethoxycarbonyl.
- Rubonyl group benzyloxyl carbonyl, benzoyloxycarbonyl group such as aryloxycarbonyl group, benzyloxy group, benzobenzyloxycarbonyl group, 3,4-dimension Toxivenge / Lessily Kisikareboninore, 2-2
- aralkyloxycarbinole groups such as shicanoreponinole, 4-nitrobenzoyloxycarbonyl or benzyl, 4-methoxybenzyl, 3,4-dimethybenzyl,
- An aralkyl group which may have a substituent, such as 2-benzyl or 4-122 benzyl, and particularly preferably benzyl, 4-methoxybenzinole, 412 benzyl. Ethoxycarbonyl, t-butoxycarbonyl or benzyloxycanolebonyl group.
- This method can be performed according to the above-mentioned method F. [0071]
- This method can be performed in an inert solvent or in the absence of a solvent, in an atmosphere of an inert gas or in an atmosphere, in the presence or absence of a base, in the presence or absence of an additive, or in the presence of a compound (29 ) Is reacted with the above-mentioned compound (1 2) to give a compound (2A), and then the protecting group Pro 1 is removed to give the compound (2A) (X 1 in the above-mentioned compound (2) Is a nitrogen atom).
- n and W1 and R10a, R20a, R21a, R22a, R23a, R30a, R31a and R32a are as defined above. .
- HPro1 has the same meaning as a hydrogen atom or the aforementioned Pro1 group.
- This method can be performed according to the above-mentioned method H. [0072]
- This method is carried out in an inert solvent, in the presence of a palladium (0) catalyst, in an atmosphere of an inert gas or in a non-atmosphere, in the presence or absence of a base, in the presence or absence of an additive,
- the compound (30) is reacted with the above-mentioned compound (14), and then the protecting group Pro1 is removed to obtain a compound (2C) (a compound of the above-mentioned compound (2), which is R 10b). It is a method of manufacturing.
- This method can be performed according to the above-mentioned K method.
- This method is carried out in an inert solvent, in the presence of a palladium (0) catalyst, in an atmosphere of an inert gas or in a non-atmosphere, in the presence or absence of a base, in the presence or absence of an additive, By reacting the compound (31) with the above-mentioned compound (16), and then removing the protecting group Pro1, the compound (2C) (the compound of the above-mentioned compound (2) which is R 10b ).
- This method can be performed according to the above-mentioned K method.
- This method comprises reacting compound (19) with compound (33) in an inert solvent, in the presence of a reducing agent, in the presence or absence of an acid, or in the presence or absence of an additive.
- a method for producing compound (2A) (the compound in which X 1 in the above compound (2) is a nitrogen atom) by removing the protecting group Pro 1a by the method described above. .
- n, Wl, El, E2 and E3 and R10a, R20a, R21a, R22a, R23a, R30a, R31a and R32a are as defined above. .
- HPro1a is a hydrogen atom or a group representing the following Pro1a.
- Pro 1 a is a aralkyl group which may have a substituent such as benzene, 4-methoxybenzyl, 3,4-dimethoxybenzyl, 2-nitrobenzyl or 4-nitrobenzyl. And preferably a benzyl group.
- This method can be performed according to the above-mentioned method C.
- the compound (34) is reacted with a base in an inert solvent, and then the protecting group Pro 1 is removed by the above-mentioned method to give the compound (2A) (X in the above-mentioned compound (2)).
- n, Wl, Prol, E4, E5 and E6 and Rl-Oa, R20a, R21a, R22a, R23a, R30a, R31a and And R 32a is as defined above.
- compound (35) is reacted with compound (9) in an inert solvent in the presence of a palladium (0) catalyst, followed by a hydrogenation reaction, and further, removing the protecting group Pro1.
- the compound (2B) (the compound in which XI in the above-mentioned compound (2) is a formula CH group) (the method 1-7-1) is used, or the compound ( This is a method for producing compound (200) by reacting 35) with compound (9) and then removing protective group Pro 1 (Method 17-2).
- n, Wla, Ml and Pro1 and R10a, R20a, R21a, R22a, R23a, R30 &, R31a and R32a are as described above. It is the same as the one.
- This method can be performed according to the above-mentioned hydrogenation reaction during the above-mentioned method K and then the method A.
- the compound (36) is reacted with the above-mentioned compound (25) in an inert solvent in the presence of a palladium (0) catalyst, followed by a hydrogenation reaction, and further, the protecting group Pro 1 A compound (2B) (compound which is a CH group represented by the formula X1 in the above compound (2)) by removing the compound (Method 18-1), or as described above.
- the compound (36) is reacted with the compound (25) to give a compound (20 OC) (a compound of the above compound (200) which is Rl Ob) by removing the protecting group Pro1.
- Method (1-1 8-2 method In the above scheme, n, Wla, MlProbe and R10a, R10b, R20a, R21a R22a, R23.a, R30a, R31a and Furthermore, R 32a is as defined above.
- This method can be performed according to the above-mentioned hydrogenation reaction during the above-mentioned method K and then the method A.
- This method comprises the steps of reacting compound (37) with compound (2) in an inert solvent in the presence of an inert gas. 7) (ie, lithium reagent or Grignard reagent) to give an adduct (160) (steps 1-9-1), and then the benzylic hydroxyl group of the resulting adduct compound (160) Is reduced (step 191-2), and the protecting group Pro 1 is removed to obtain a compound (2B) (a compound in which X 1 in the above compound (2) is a CH group of the formula) Or the reaction in the same manner as described above to obtain an adduct (160) (step 191-11). Then, the hydroxyl group of the compound (160) is converted into a compound in the presence of an acid. Alternatively, dehydration is performed in the absence (steps 1-9-3), and the protecting group Pro 1 is further removed to remove the ligated compound (200 C) (R 1 Ob in the above compound (200)). (A certain compound).
- 7) ie, lithium reagent
- n, M2 and Pro1 and R10a, R10b, R20a, R21a, R22a, R23a, R30a, R31a and R32a are It is as defined above.
- This method can be performed according to the above-mentioned U method.
- E 7 is also a group suitable for obtaining the desired group of formula E 2 (CO) E 1—.
- Step 2-1 and step 2-2 can be performed according to the above-mentioned Method A. (2-3 steps)
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- the solvent is formaldehyde, dichloromethane, 1,2-dichloroethane.
- halogenated hydrocarbons such as carbon tetrachloride, and nitrinoles such as acetonitrile and isobutyronitrile.
- Halogenated hydrocarbons particularly dichloromethane are preferred.
- the oxidizing agent to be used is not particularly limited as long as it can obtain a target compound and does not produce an inseparable by-product.
- PCC pyridinium dichromate
- DDC Dess-Martin reagent
- Martin JC J. Am. Chem. Soc.
- TPAP perruthenate
- VI perruthenate tetrapropylammonium
- NMO N-methylmorpholine-N-oxide
- Swern oxidizing agent dimethylsulfoxide oxidizing agents such as dimethylsulfoxide monochloride (D. Swern et al., Synthesis, (1981), 165) And dimethyl sulfoxide oxalyl chloride (Swern oxidizing agent).
- the additive used is not particularly limited as long as it can obtain a target compound and does not generate strong and inseparable by-products. And preferably a molecular sieve.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 180 to 60 ° C, preferably from 180 to 40 ° C.
- the reaction time varies depending on the starting materials, solvent, reagents and reaction temperature, but is usually 0.1 to 100 hours, preferably 1 to 12 hours.
- the compound (38), compound (39) or compound (19) can be isolated or purified from the reaction mixture obtained above by the method described above. [0080]
- compound (40) is reacted with an N-alkylating agent or an N-carbonylating agent in an inert solvent to obtain compound (41) (step 3-1). )
- compound (42) is reacted with compound (1 2) to give compound (21) or compound (34). It is a production method (3-3 steps).
- E 8 is also a group suitable for obtaining the desired group of formula E 4 (CO) E 5.
- PR 4 O a is a force ⁇ or a protecting group for an amino group (preferably a t-butoxycarbonyl group or a benzyl group) having the same meaning as R 40 a described above.
- Step 3-1 of the present method can be performed according to the above-mentioned method A. Also, step 31 can be performed according to the above-mentioned method 2 (step 2-3), Further, step 3-3 can be performed according to the above-mentioned method C. [008 1]
- compound (24A) or compound (36A) is obtained by introducing a trifluoromethanesulfonyl group into compound (43) under an inert gas atmosphere in an inert solvent (step 411). Then, the compound (24A) or the compound (36A) is reacted with a boron metal reagent or a tin metal reagent in the presence of a palladium (0-valent) catalyst to obtain the aforementioned compound (22) or compound (35) ( 4-2 step), and a method for producing compound (24B) or compound (36B) by reacting compound (22) or compound (35) with a halogenating reagent in the presence or absence of a base and a compound (22) or compound (35) (About 4_3). In addition, this is a method of reacting compound (43) directly with a halogenating agent to produce compound (24B) or compound (36B) (steps 4 to 4).
- n and R 30a, R 31a, R 32a and PR40 a are as defined above.
- Ha 1 represents a chlorine atom, a bromine atom or an iodine atom.
- Mlb represents two groups of the formula B (OE 10c ) or three groups of the formula Sn (E 10b ), wherein E 10c is a C 1-6 alkyl group or two of which are substituted with a methyl group Represents a C 2-3 alkylene group, and E 10b represents a C 1-6 alkyl group).
- T f is a trifluoromethanes / norefoni / re group.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction of this step.
- ethers such as getyl ether, tetrahydrofuran, and dioxane are used. 'And preferably tetrahydrofuran.
- This method is preferably carried out in a dry inert gas atmosphere.
- Argon or nitrogen is preferred as the inert gas. .
- the base to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- lithium bis (trimethylsilyl) amide And alkali metal amides such as sodium bis (trimethinoresilinole) amide and lithium diisopropyl amide, and preferably lithium bis (trimethylsilyl) amide or lithium disopropyl amide.
- the trifluoromethanesulfonylation reagent is not particularly limited as long as it can obtain the target compound and does not generate an inseparable by-product.
- N-phenylbis Trifluoromethanesulfonimide.
- the reaction temperature for the enolization varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 10 Q to 20 ° C., preferably from 180 to 130 ° C.
- the reaction temperature at the time of conversion to a leaving group varies depending on the starting material, solvent and reagent, but is usually from 100 to 50 ° C, preferably from 180 to 30 ° C.
- the reaction time for enolization depends on the starting materials, solvents, reagents and reaction temperature, Usually, it is from 0.1 to 5 hours, preferably from 0.1 to 3 hours.
- reaction time for the conversion to a leaving group varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 0.1 to 24 hours, preferably 0.5 to 12 hours. You.
- 2,6-di-tert-butyl is used in an inert solvent such as dichloromethane, as described in David Crich et.al., Synthesis, (2001), 2, 323, etc. 4
- Compound (44) can also be produced by reacting ketone compound (43) with trifluoromethanesulfonic anhydride in the presence of an organic base such as monomethylpyridine.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- Specific examples include, but are not limited to, amides such as formamide, dimethylformamide, dimethylacetamide, and hexamethylphosphoric triamide; or sulfoxides such as dimethyl sulfoxide and sulfolane; And ethers such as diisopropyl ether, tetrahydrofuran, dihydroxan, dimethoxyxan, dimethoxetane, and diethyleneglyconoresinethylene ether; and aromatic hydrocarbons such as benzene, toluene, and xylene. , Dimethyl sulfoxide and dioxane.
- the metal catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- [1, 1′— Bivalent palladiums such as bis (diphen-norephosphino) triphenylphosphine] palladium (II) chloride, and zero-valent palladiums such as tetrakistriphenylphosphine palladium can be mentioned.
- Examples of the base used include potassium phenoxide, triethylamine, potassium phosphate, potassium carbonate, and potassium acetate, and preferably potassium acetate.
- Catalysts used include triphenylarsine.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually 50 to 80 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 6 hours, preferably 2 to 3 days.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- formamide, dimethylformamide, dimethylacetamide And amides such as hexamethylphosphate triamide.
- Ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycolone resin methinole ether can be mentioned.
- ethers particularly tetrahydrofuran are used. is there.
- the metal catalyst to be used is not particularly limited as long as the target compound can be obtained and does not generate inseparable by-products. Specifically, tetrakis (triphenylphosphine) is used. ) Zero-valent palladiums such as radium (0) and tris (dibenzylidene cetone) dipalladium (0) can be mentioned.
- Tin reagents used include hexamethylditin (IV) and hexabutylditin. Tin (IV) and hexafenyldistin (IV) are preferred, and hexamethyldistin (IV) is preferred.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 170 to 80 ° C, preferably from 50 to 80 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 8 hours, preferably 2 to 4 hours. .
- Kurt Ritter et al., Synthesis 1993; 735-762 can be cited as a document supplementing the above method.
- the solvent used is not particularly limited, as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- the solvent is formaldehyde, dichloromethane, 1,2-dichloroethane.
- halogenated hydrocarbons such as carbon tetrachloride, and ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxan, dimethoxetane, and diethylene glycolone resin methylene ether.
- ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxan, dimethoxetane, and diethylene glycolone resin methylene ether.
- dichloromethane carbon tetrachloride, ethyl ether, tetrahydrofuran.
- the halogenating reagent used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product. Specifically, chlorine, bromine, and iodine are used. N-chlorosuccinimide, N-bromosuccinimide
- N-iodosuccinic acid imid N-iodosuccinic acid imid
- copper chloride Preferred are chlorine, bromine, and iodine.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 178 to 25 ° C, preferably from 0 to 25 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 24 hours, preferably 1 to 6 hours.
- the solvent to be used is not particularly limited as long as it does not dissolve the compound to some extent and does not inhibit the reaction of this step.
- Halogenated hydrocarbons such as chloromethane, 1,2-dichloroethane, and carbon tetrachloride; and aromatic hydrocarbons such as benzene, toluene, and xylene can be mentioned. They are dichloromethane and carbon tetrachloride.
- the halogenating agent to be used is not particularly limited as long as it can obtain a target compound and does not generate an inseparable by-product, but specific examples thereof include chlorine and oxalic acid.
- the reaction temperature varies depending on the starting substance, solvent and reagent, but is usually 0 to 70 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction time, but is usually 1 to 24 hours.
- This method comprises reacting compound (45) with compound (14) in an inert solvent in the presence of a palladium (0) catalyst to obtain compound (9A) (step 5-1).
- (9A) is reacted with a lithiating agent or a Grignard reagent to give compound (27) (step 5-2).
- compound (27) is reacted with a boron metal reagent or a tin metal reagent to obtain compound (27).
- Ml, Mlb and M2 and R10b, R20a, R-21a, R22a and R23a are as defined above.
- Hall is a chlorine atom or a bromine atom
- Ha12 is an iodine atom when Ha11 is a bromine atom
- the 5-1 step of this method can be performed according to the above-mentioned K method.
- the method of this step differs depending on M2.
- the compound (9A) is reacted directly with magnesium metal in an inert solvent (direct method), or a magnesium-halogen exchange reaction between the compound (9A) and another Grignard reagent is performed.
- direct method This is a method for producing the compound (27) (ie, Grignard reagent).
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethyl examples thereof include ethers such as toxetane and diethylene glycol dimethyl ether, and phosphoric amides such as hexamethylene / relionic acid triamide, and preferred are ethers (especially getyl ether or tetrahydrofuran).
- the reaction is carried out according to a conventional method.
- Metal magnesium is suspended in the above solvent under an inert gas atmosphere such as nitrogen or argon, in the presence or absence of a catalytic amount of iodine or dibromoethane as an activating agent, and the compound ( 9 A) is slowly added to the reaction system.
- the compound (27) is produced in the supernatant, and is usually used in the next step without isolation.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 20 to 150 ° C., preferably from 0 to 100 ° C.
- reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually 1 to 10 hours.
- reaction is carried out according to a conventional method. However, under an atmosphere of an inert gas such as nitrogen or argon, a halogen compound (9A) is reacted with isopropylmagnesium bromide or the like to give a compound (27) (that is, an organic magnesium compound). Compound) can be produced. The resulting compound (27) is usually used in the next step without isolation.
- an inert gas such as nitrogen or argon
- the halogen-containing compound (9A) is reacted with another alkyllithium reagent in an inert solvent under an inert gas atmosphere such as nitrogen or argon, and the aryl-lithium reagent is reacted.
- an inert gas atmosphere such as nitrogen or argon
- ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycol dimethyl ether.
- ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, and diethylene glycol dimethyl ether.
- phosphoric acid amides such as xamethinorellinic acid triamide, and preferably ethers (especially getyl ether or tetrahydrofuran).
- the alkyllithium reagent to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product.
- n-butyllithium, Alkyl lithiums such as sec-butyllithium and t-butylinolelithium can be mentioned, and preferably n-butyllithium.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 100 to 0 ° C.
- reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually from 10 minutes to 2 hours.
- the resulting compound (27) is usually used in the next step without isolation.
- the lithiating agent or Grignard reagent (27) produced in step 5-2 is reacted with a boronic ester reagent shown below to produce a boronic acid reagent compound (25).
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane examples include ethers such as dimethoxetane, diethyleneglycol / resimethinole ether, and phosphoric amides such as hexamethylphosphoric acid triamide, preferably ethers (particularly getyl ether or tetrahydrofuran). It is.
- the boronate ester reagent to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product. Specifically, triisopropylpropylborane is used. Trialkyl borate esters such as acid esters and trimethyl borate esters can be mentioned, and preferably triisopropyl borate ester.
- the trialkylborates obtained here can be easily hydrolyzed with water or an aqueous solution of ammonium chloride, and the boronic acid reagent compound (25) can be produced.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from 180 to 50 ° C, preferably from 180 to 30 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 10 hours, preferably 2 to 6 hours.
- This method uses a lithiating agent or Grignard reagent (27)
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- dimethyl ether, diisopropyl ether, tetrahydrofuran examples thereof include ethers such as dioxane, dimethoxetane, and diethylene glycol dimethyl ether, and phosphoric amides such as hexamethinorellinic triamide.
- ethers particularly, getyl ether or tetrahydrofuran).
- the trialkyltin halide reagent to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product. Specifically, triptyltin chloride is used. And halotrialkyltins such as trimethyltin chloride. Preferred is triptyltin chloride.
- the reaction temperature varies depending on the starting materials, solvents and reagents, but is usually from ⁇ 80 to 50 ° C., preferably from 180 to 30 ° C.
- the reaction time varies depending on the starting material, solvent, reagent and reaction temperature, but is usually 1 to 10 hours, preferably 1 to 6 hours.
- This method comprises reacting compound (46) with compound (14) in an inert solvent in the presence of a palladium (0) catalyst to obtain compound (47) (step 6-1).
- Compound (48) is obtained by reacting (47) with a dealkylating agent or a dearalkylating agent (step 6-2), and further, a trifluoromethanesulfonyl group is introduced into the phenolic hydroxyl group of compound (48).
- step 6-3 for producing compound (9B).
- R 100 represents a C 16 alkyl group or a substituted or unsubstituted aralkyl group, and is preferably a methyl group or a benzyl group.
- Step 6-1 of this method can be carried out according to the above-mentioned K method (Step 5-2)
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- Specific examples of the solvent include methanol, ethanol, and isopropanol.
- Alcohols, ethers such as dimethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, dimethoxetane, ethylene glycolone resin, aromatic hydrocarbons such as benzene, tonylene, xylene,
- Organic acids such as carbon disulfide, acetic acid, hydrogen bromide and acetic acid solution; organic bases such as quinoline and pyridine; and water. These are appropriately selected as the dealkylating agent or dearalkylating agent to be used.
- the dealkylating agent or dearalkylating agent used is not particularly limited as long as it can obtain the target compound and does not generate an inseparable by-product.
- Lewis acids such as boron tribromide, boron trichloride, boron triiodide, aluminum chloride, Bronsted acids such as hydrobromic acid, hydrochloric acid, and hydrogen bromide acetic acid solution;
- Metal salts such as lithium and halosilanes such as trimethylsilane iodide can be mentioned.
- the reaction temperature varies depending on the starting materials, solvents and reagents, and is usually 180 to 250 ° C. .
- reaction time varies depending on the starting materials, solvent, reagents and reaction temperature, but is usually 0.1 to 100 hours.
- the dearalkyl group step can also be performed by the hydrogenation method described above in Method A.
- step 6-3 can be performed according to the above-mentioned method A or method B.
- compound (9C) is reacted with a boron metal reagent or a tin metal reagent in an inert solvent in the presence of a palladium (0) catalyst to produce compound (25A).
- Mlb and Ha1 are as defined above.
- This method can be performed according to (4-2 steps) of the four methods.
- the method is carried out in an inert solvent, in the presence of a palladium (0) catalyst or a copper catalyst, in the presence or absence of a base, in the presence or absence of additives, in an atmosphere of an inert gas or in a non-atmosphere.
- the compound (49) is reacted with the above-mentioned compound (8) (Amination or Amidation) to obtain a compound (50) (step 8-1), and then to a dealkylated compound (50).
- Compound (51) is obtained by reacting the compound or dearalkylating agent (Step 8-2).
- compound (13A) is obtained by introducing a trifluoromethanesulfonyl group into the phenol / raw hydroxyl group of compound (51). This is a method (8-3 steps) for producing.
- Tf, n, R20a, R21a, R22a, R23a, R30a, R31a, R32a, R40a and R100 are as described above. I agree. MW1a has the same meaning as Mla or Wla described above.
- Step 8-1 of the present method can be carried out according to the above-mentioned Method F or Method G, and Step 8-2 can be carried out according to the above-mentioned Step 6-2.
- the demonstration can be carried out in accordance with the aforementioned Law A or Law B.
- This method is performed in an inert solvent, in the presence of a palladium (0) catalyst or a copper catalyst, in the presence or absence of a base, in the presence or absence of additives, in an inert gas atmosphere.
- the compound (77) is reacted with the above-mentioned compound (8) under or without an atmosphere to obtain a compound (13B) (step 9-11), and then a metal reagent is reacted with the compound (1.3 B).
- This is a method (9-12 step) for producing compound (15).
- n and Ml and R20a, R21a, R22a, R23a, R30a, R31a, R32a, and R40a are as defined above.
- Ha 14 is a chlorine atom or a bromine atom
- Ha 13 is an iodine atom when Ha 14 is a bromine atom
- a bromine atom or iodine atom when Ha 14 is a chlorine atom.
- Step 911 of the present method can be carried out according to the above-mentioned method F, and step 912 can be carried out according to the above-mentioned step 5-2 and step 5-3 or method 7. it can.
- R 10b — Hal (16B) (14) R 10b — M 1b This method is to introduce a leaving group into compound (53) in an inert solvent, in an inert gas atmosphere or under no atmosphere. 6A) (Step 10-1), and then reacting compound (16A) with a boron metal reagent or a tin metal reagent in the presence of a palladium (0-valent) catalyst to obtain compound (14) (10—1). 2) and a method of reacting compound (14) with a halogenating reagent to produce compound (16B) (10-3 steps).
- this is a method of reacting compound (53) directly with a halogenating agent to produce compound (16B) (step 10-4).
- T f, R 10b, Mlb and Ha 1 are as defined above.
- R 200 is the same as the substituent contained in the aforementioned substituent group A1. Or a substituent on those substituents is a protected group.
- u is an integer of 0, 1, 2, 3, 4 or 5.
- k is an integer of 0, 12, 3, 4, or 5.
- the 10-1 step of the present method can be carried out according to the above-mentioned 4-1 method, and the 10-2 step can be carried out according to the 4-2 method described above. Further, the 10-3 step can be performed according to the above-mentioned 4-3 method. The 10-4 steps can be performed according to the above-mentioned 414 step.
- compound (54) is reacted with a nitrating reagent to obtain compound (55) (step 11), and then compound (54) is prepared using a metal or metal salt in the presence of an acid. 55) to produce compound (1 2) by reducing (112).
- R10a, R20a, R21a, R22a and R23a are as defined above.
- the solvent to be used is not particularly limited as long as it does not dissolve the starting compound to some extent and inhibits the reaction in this step.
- a mixed solvent of sulfuric acid and nitric acid, a mixed solvent of acetic acid and nitric acid Nitric acid, which is a solvent reacts as a nitrating agent.
- the reaction temperature varies depending on the starting material, solvent and reagent, but is usually from ⁇ 20 to 150 ° C., preferably from 0 to 80 ° C.
- the reaction time varies depending on the starting materials, solvents, reagents and reaction temperature, but is usually 0.5 to 48 hours, preferably 1 to 12 hours.
- the solvent used is not particularly limited as long as it does not dissolve the starting compound to some extent and does not inhibit the reaction in this step.
- alcohols such as water, methanol, and ethanol; Examples thereof include amides such as formamide, dimethylformamide, dimethylacetamide, and hexamethylphosphoric triamide; organic acids such as acetic acid; and a mixed solvent thereof.
- the metal or metal salt to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product, but specific examples thereof include iron powder and tin.
- Metals such as powder and zinc powder, and metal salts such as tin (II) chloride can be mentioned, and metals (particularly, iron powder) are preferable.
- the acid to be used is not particularly limited as long as the target compound can be obtained and does not generate an inseparable by-product, and specific examples thereof include organic acids such as acetic acid, Inorganic acids such as hydrochloric acid and ammonium chloride can be mentioned, preferably ammonium chloride.
- the equivalent of the metal or metal salt used depends on the starting material, solvent, and reagent.
- the molar ratio is usually 2 to 15 times, preferably 3 to 6 times, the molar ratio to the starting material. .
- the reaction temperature varies depending on the starting material, solvent and reagent, but is usually from 0 to 150 ° C, and preferably from 0 to 100 ° C.
- the reaction time depends on the starting materials, solvent, reagents and reaction temperature, but is usually 0.5 To 48 hours, preferably 1 to 12 hours.
- the compound (55) or the compound (12) can be isolated or purified from the reaction mixture obtained as described above by the method described above.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0418152A BRPI0418152B8 (pt) | 2003-12-26 | 2004-12-24 | compostos de benzeno substituído por 1,2-di(cíclico), medicamento compreendendo os mesmos, agente terapêutico, inibidor de adesão celular, bem como seu uso |
EP04808145.9A EP1698620B1 (en) | 2003-12-26 | 2004-12-24 | Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
MXPA06007248A MXPA06007248A (es) | 2003-12-26 | 2004-12-24 | Compuestos de benceno 1,2-di(ciclico)sustituido. |
NZ547498A NZ547498A (en) | 2003-12-26 | 2004-12-24 | Benzene compounds disubstituted with cyclic groups at the 1- and 2- positions |
AU2004309280A AU2004309280B2 (en) | 2003-12-26 | 2004-12-24 | Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
CA002545999A CA2545999C (en) | 2003-12-26 | 2004-12-24 | 1,2-di(cyclic)substituted benzene compounds |
JP2005516735A JP4411283B2 (ja) | 2003-12-26 | 2004-12-24 | 1,2−ジ(環式基)置換ベンゼン化合物 |
US10/581,591 US7410971B2 (en) | 2004-12-24 | 2004-12-24 | 1,2-di(cyclic)substituted benzene compounds |
ES04808145.9T ES2606379T3 (es) | 2003-12-26 | 2004-12-24 | Compuestos de benceno disustituidos con grupos cíclicos en las posiciones 1 y 2 |
IL176160A IL176160A (en) | 2003-12-26 | 2006-06-06 | Compounds that prevent adhesion and infiltration of cells and pharmaceutical preparations containing them |
NO20063407A NO336948B1 (no) | 2003-12-26 | 2006-07-24 | 1,2-di(cyclisk)substituerte benzenforbindelser, medikament omfattende slike forbindelser, slike forbindelser for bruk som medikament og slike forbindelser for anvendelse i terapi for behandling av sykdom |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003435050 | 2003-12-26 | ||
JP2003-435050 | 2003-12-26 | ||
JP2003434312 | 2003-12-26 | ||
JP2003-434312 | 2003-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005063705A1 true WO2005063705A1 (ja) | 2005-07-14 |
Family
ID=34742148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/019795 WO2005063705A1 (ja) | 2003-12-26 | 2004-12-24 | 1,2-ジ(環式基)置換ベンゼン化合物 |
Country Status (16)
Country | Link |
---|---|
US (1) | US7425554B2 (ja) |
EP (1) | EP1698620B1 (ja) |
JP (1) | JP4411283B2 (ja) |
KR (1) | KR100782966B1 (ja) |
AU (1) | AU2004309280B2 (ja) |
BR (1) | BRPI0418152B8 (ja) |
CA (1) | CA2545999C (ja) |
ES (1) | ES2606379T3 (ja) |
IL (1) | IL176160A (ja) |
MX (1) | MXPA06007248A (ja) |
MY (1) | MY140489A (ja) |
NO (1) | NO336948B1 (ja) |
NZ (1) | NZ547498A (ja) |
RU (1) | RU2340602C2 (ja) |
TW (1) | TW200530200A (ja) |
WO (1) | WO2005063705A1 (ja) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006068058A1 (ja) * | 2004-12-20 | 2006-06-29 | Eisai R & D Management Co., Ltd. | 1-シクロプロピルメチル-4-[2-(3,3,5,5-テトラメチルシクロヘキシル)フェニル]ピペラジンの塩および結晶 |
WO2006126635A1 (ja) * | 2005-05-25 | 2006-11-30 | Eisai R & D Management Co., Ltd. | [2-(3,3,5,5-テトラメチルシクロヘキシル)フェニル]ピペラジン化合物の製造中間体 |
WO2006134955A1 (ja) * | 2005-06-14 | 2006-12-21 | Eisai R & D Management Co., Ltd. | 1,2-ジ(環式基)置換ベンゼン誘導体 |
US7410971B2 (en) | 2004-12-24 | 2008-08-12 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic)substituted benzene compounds |
US7425554B2 (en) | 2003-12-26 | 2008-09-16 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic)substituted benzene compounds |
JP2015083970A (ja) * | 2013-09-20 | 2015-04-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 化合物の抗炎症効果または免疫抑制効果を予測する方法 |
WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
US11116760B2 (en) | 2018-10-30 | 2021-09-14 | Gilead Sciences, Inc. | Quinoline derivatives |
US11174256B2 (en) | 2018-10-30 | 2021-11-16 | Gilead Sciences, Inc. | Imidazopyridine derivatives |
US11179383B2 (en) | 2018-10-30 | 2021-11-23 | Gilead Sciences, Inc. | Compounds for inhibition of α4β7 integrin |
US11224600B2 (en) | 2018-10-30 | 2022-01-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
US11578069B2 (en) | 2019-08-14 | 2023-02-14 | Gilead Sciences, Inc. | Compounds for inhibition of α4 β7 integrin |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050223109A1 (en) * | 2003-08-27 | 2005-10-06 | Ascential Software Corporation | Data integration through a services oriented architecture |
US20060276465A1 (en) * | 2003-12-26 | 2006-12-07 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic) substituted benzene compounds |
DE602006016439D1 (de) * | 2005-05-25 | 2010-10-07 | Eisai R&D Man Co Ltd | Verfahren zur herstellung von ä2-(3,3,5,5-tetramethylcyclohexyl)phenylüpiperazin |
AU2011290238B8 (en) * | 2010-08-09 | 2015-09-03 | Nb Health Laboratory Co. Ltd. | Inhibitor of casein kinase 1delta and casein kinase 1E |
CN102295707B (zh) * | 2011-08-15 | 2013-07-31 | 上海西达实业有限公司 | 低粘度羧甲基淀粉及其制备方法和应用 |
WO2013114332A1 (en) | 2012-02-02 | 2013-08-08 | Actelion Pharmaceuticals Ltd | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
MX363432B (es) | 2013-07-22 | 2019-03-22 | Idorsia Pharmaceuticals Ltd | Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona. |
AR099789A1 (es) | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
ES2709985T3 (es) | 2015-01-15 | 2019-04-22 | Idorsia Pharmaceuticals Ltd | Derivados de hidroxialquil-piperazina como moduladores del receptor CXCR3 |
TWI707683B (zh) | 2018-06-13 | 2020-10-21 | 美商輝瑞股份有限公司 | Glp-1受體促效劑及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05186434A (ja) * | 1991-06-27 | 1993-07-27 | Synthelabo Sa | 4−ピリミジンカルボキサミド誘導体、その製造方法および治療への応用 |
WO2002059108A1 (en) * | 2001-01-23 | 2002-08-01 | Eli Lilly And Company | Melanocortin receptor agonists |
JP2003506377A (ja) * | 1999-07-28 | 2003-02-18 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
WO2003033466A1 (fr) * | 2001-10-18 | 2003-04-24 | Sanofi-Synthelabo | Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688795A (en) * | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
PT748800E (pt) * | 1995-06-09 | 2001-10-30 | Hoffmann La Roche | Derivados de pirimidinadiona pirimidinatriona triazinadiona como antagonistas do receptor alfa-1-adrenergico |
US20020169155A1 (en) | 1998-09-04 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Chemokine receptor anagonists and methods of use therefor |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
WO2005005382A2 (en) | 2003-07-02 | 2005-01-20 | Cytokinetics, Inc. | Compounds, compositions and methods |
MY140489A (en) | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
CN101068798B (zh) * | 2004-12-20 | 2010-05-12 | 卫材R&D管理有限公司 | 1-环丙基甲基-4-[2-(3,3,5,5-四甲基环己基)苯基]哌嗪的盐及结晶 |
WO2006126635A1 (ja) | 2005-05-25 | 2006-11-30 | Eisai R & D Management Co., Ltd. | [2-(3,3,5,5-テトラメチルシクロヘキシル)フェニル]ピペラジン化合物の製造中間体 |
-
2004
- 2004-12-22 MY MYPI20045297A patent/MY140489A/en unknown
- 2004-12-24 BR BRPI0418152A patent/BRPI0418152B8/pt not_active IP Right Cessation
- 2004-12-24 NZ NZ547498A patent/NZ547498A/en not_active IP Right Cessation
- 2004-12-24 EP EP04808145.9A patent/EP1698620B1/en active Active
- 2004-12-24 MX MXPA06007248A patent/MXPA06007248A/es active IP Right Grant
- 2004-12-24 KR KR1020067012930A patent/KR100782966B1/ko active IP Right Grant
- 2004-12-24 CA CA002545999A patent/CA2545999C/en not_active Expired - Fee Related
- 2004-12-24 RU RU2006127047/04A patent/RU2340602C2/ru not_active IP Right Cessation
- 2004-12-24 JP JP2005516735A patent/JP4411283B2/ja active Active
- 2004-12-24 WO PCT/JP2004/019795 patent/WO2005063705A1/ja active Application Filing
- 2004-12-24 AU AU2004309280A patent/AU2004309280B2/en not_active Ceased
- 2004-12-24 ES ES04808145.9T patent/ES2606379T3/es active Active
- 2004-12-27 TW TW093140860A patent/TW200530200A/zh not_active IP Right Cessation
- 2004-12-27 US US11/022,702 patent/US7425554B2/en active Active
-
2006
- 2006-06-06 IL IL176160A patent/IL176160A/en active IP Right Grant
- 2006-07-24 NO NO20063407A patent/NO336948B1/no not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05186434A (ja) * | 1991-06-27 | 1993-07-27 | Synthelabo Sa | 4−ピリミジンカルボキサミド誘導体、その製造方法および治療への応用 |
JP2003506377A (ja) * | 1999-07-28 | 2003-02-18 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
WO2002059108A1 (en) * | 2001-01-23 | 2002-08-01 | Eli Lilly And Company | Melanocortin receptor agonists |
WO2003033466A1 (fr) * | 2001-10-18 | 2003-04-24 | Sanofi-Synthelabo | Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant |
Non-Patent Citations (1)
Title |
---|
See also references of EP1698620A4 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7425554B2 (en) | 2003-12-26 | 2008-09-16 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic)substituted benzene compounds |
CN101068798B (zh) * | 2004-12-20 | 2010-05-12 | 卫材R&D管理有限公司 | 1-环丙基甲基-4-[2-(3,3,5,5-四甲基环己基)苯基]哌嗪的盐及结晶 |
KR101274879B1 (ko) * | 2004-12-20 | 2013-06-14 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 1-시클로프로필메틸-4-[2-(3,3,5,5-테트라메틸시클로헥실)페닐]피페라진의 염 및 결정 |
US7910734B2 (en) | 2004-12-20 | 2011-03-22 | Eisai R&D Management Co., Ltd. | Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine |
WO2006068058A1 (ja) * | 2004-12-20 | 2006-06-29 | Eisai R & D Management Co., Ltd. | 1-シクロプロピルメチル-4-[2-(3,3,5,5-テトラメチルシクロヘキシル)フェニル]ピペラジンの塩および結晶 |
US7410971B2 (en) | 2004-12-24 | 2008-08-12 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic)substituted benzene compounds |
WO2006126635A1 (ja) * | 2005-05-25 | 2006-11-30 | Eisai R & D Management Co., Ltd. | [2-(3,3,5,5-テトラメチルシクロヘキシル)フェニル]ピペラジン化合物の製造中間体 |
WO2006134955A1 (ja) * | 2005-06-14 | 2006-12-21 | Eisai R & D Management Co., Ltd. | 1,2-ジ(環式基)置換ベンゼン誘導体 |
JP2015083970A (ja) * | 2013-09-20 | 2015-04-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 化合物の抗炎症効果または免疫抑制効果を予測する方法 |
WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
US11116760B2 (en) | 2018-10-30 | 2021-09-14 | Gilead Sciences, Inc. | Quinoline derivatives |
US11174256B2 (en) | 2018-10-30 | 2021-11-16 | Gilead Sciences, Inc. | Imidazopyridine derivatives |
US11179383B2 (en) | 2018-10-30 | 2021-11-23 | Gilead Sciences, Inc. | Compounds for inhibition of α4β7 integrin |
US11224600B2 (en) | 2018-10-30 | 2022-01-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
US11578069B2 (en) | 2019-08-14 | 2023-02-14 | Gilead Sciences, Inc. | Compounds for inhibition of α4 β7 integrin |
Also Published As
Publication number | Publication date |
---|---|
AU2004309280B2 (en) | 2007-10-04 |
US7425554B2 (en) | 2008-09-16 |
MY140489A (en) | 2009-12-31 |
NZ547498A (en) | 2009-10-30 |
BRPI0418152B8 (pt) | 2021-05-25 |
BRPI0418152A (pt) | 2007-04-27 |
AU2004309280A1 (en) | 2005-07-14 |
TW200530200A (en) | 2005-09-16 |
BRPI0418152B1 (pt) | 2019-02-12 |
IL176160A (en) | 2012-10-31 |
MXPA06007248A (es) | 2006-08-31 |
IL176160A0 (en) | 2006-10-05 |
EP1698620A1 (en) | 2006-09-06 |
NO20063407L (no) | 2006-09-26 |
CA2545999C (en) | 2010-01-05 |
RU2340602C2 (ru) | 2008-12-10 |
US20050261291A1 (en) | 2005-11-24 |
KR100782966B1 (ko) | 2007-12-07 |
JP4411283B2 (ja) | 2010-02-10 |
KR20070026348A (ko) | 2007-03-08 |
NO336948B1 (no) | 2015-11-30 |
EP1698620B1 (en) | 2016-09-28 |
TWI371448B (ja) | 2012-09-01 |
RU2006127047A (ru) | 2008-02-10 |
ES2606379T3 (es) | 2017-03-23 |
CA2545999A1 (en) | 2005-07-14 |
JPWO2005063705A1 (ja) | 2007-07-19 |
EP1698620A4 (en) | 2008-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005063705A1 (ja) | 1,2-ジ(環式基)置換ベンゼン化合物 | |
US4584303A (en) | N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds | |
EP1040103B1 (en) | Anilide derivative, production and use thereof | |
WO1996033973A1 (fr) | Derives disubstitues en position 1,4 de piperidine | |
US4198417A (en) | Phenoxyphenylpiperidines | |
CN105330595B (zh) | 吡啶衍生物及其作为抗分支杆菌的应用 | |
US20060276465A1 (en) | 1,2-di(cyclic) substituted benzene compounds | |
WO2006134955A1 (ja) | 1,2-ジ(環式基)置換ベンゼン誘導体 | |
JPH06508353A (ja) | 化合物 | |
JPH021478A (ja) | 二置換ピリジン類 | |
WO1994018172A1 (en) | Imidazolylbenzene compound and use thereof as medicine | |
DE19601938A1 (de) | Neue Phosphodiesteraseinhibitoren | |
US4668690A (en) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans useful as analgesics, anticonvulsants or antidepressants | |
US4198419A (en) | Phenylthiophenylpiperidines | |
US7410971B2 (en) | 1,2-di(cyclic)substituted benzene compounds | |
US4104402A (en) | 5,6-Dihydroxy aminotetralol compounds | |
CN100526301C (zh) | 1,2-二(环式基)取代苯化合物 | |
JPS58213756A (ja) | 4−アリ−ル−4−ピペリジンカルビノ−ル類 | |
JPS588076A (ja) | (+)−(4r,6s)−(e)−6−〔2−(4′−フルオロ−3,3′,5−トリメチル−〔1,1′−ビフエニル〕−2−イル)エテニル〕−3,4,5,6−テトラヒドロ−4−ヒドロキシ−2h−ピラン−2−オ | |
JPH059175A (ja) | スチリル化合物およびその医薬用途 | |
MX2007015506A (es) | Derivado de benceno 1,2-di(grupo ciclico)sustituido. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480038660.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005516735 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2545999 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12006500978 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 547498 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004309280 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007112002 Country of ref document: US Ref document number: 10581591 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 176160 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2004309280 Country of ref document: AU Date of ref document: 20041224 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006/05157 Country of ref document: ZA Ref document number: 200605157 Country of ref document: ZA Ref document number: PA/a/2006/007248 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2004309280 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2004808145 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004808145 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067012930 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200601086 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006127047 Country of ref document: RU Ref document number: 2748/CHENP/2006 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004808145 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067012930 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0418152 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 10581591 Country of ref document: US |